Preparing content…

Cytogenetic Technologists

SOC 29-2011 · O*NET 29-2011.01

Chromosome analysis · Cell culture and slide preparation · Result interpretation and reportingO*NET-SOC 29-2011.01 · U.S. wages and employment follow the parent-occupation proxy basis · Review boundariesSpecimen handling · Culture and harvest · Banding and slide preparation · Karyotype interpretation and FISH · Recording and quality
25%AI Impact ScoreFermatMind / 费马测试

Cytogenetic technologists prepare specimens, stain or hybridize slides, and examine chromosome number and structure. They document quality issues and submit findings under laboratory procedures. Result approval and clinical interpretation follow local roles and institutional rules.

Model impact index for three equally weighted representative core tasks; not a measured share of working time or a job-loss probability. floor((0+0+75)/3+0.5)=25; fermatmind-ai-impact-v1; 2026-10-18.

62,930 dollars per year (median, 2025 wage data; hourly 30.26 dollars; parent-occupation proxy basis)U.S. median wage · Clinical Laboratory Technologists and TechniciansU.S. Bureau of Labor Statistics
+2.7%U.S. projected employment change (2025–2035) · Clinical Laboratory Technologists and TechniciansU.S. Bureau of Labor Statistics
343,000 jobs (2025)U.S. employment (2025) · Clinical Laboratory Technologists and TechniciansU.S. Bureau of Labor Statistics
20,800 annually (including replacements)U.S. projected annual openings (including replacements) · Clinical Laboratory Technologists and TechniciansU.S. Bureau of Labor Statistics
No data availableMainland China: occupation wage unavailable

Quick judgment

Judgment focus: whether, on the premise that the specimen identity chain, culture and harvest conditions and interpretation standards are all constrained, you can turn specimen processing, culture and slide preparation, karyotype interpretation and result reporting into test records that are verifiable, reviewable and traceable.

The work is mainly laboratory-based, often involving long periods of fine observation and interpretation at a microscope, and requires managing cell culture, slide preparation and banding processes in batches; the processes differ markedly across specialty directions (classical cytogenetics, FISH, aCGH) and institution types.The core output is accurate, reviewable and traceable test results and records: specimen assessment and processing records, culture and harvest conditions, banding method and slide quality records, karyograms and analysis conclusions named according to ISCN, FISH or aCGH analysis results, and quality control and equipment maintenance records — not "how many cases you did".

Similar job titles among adjacent occupations do not mean the same duties; when comparing, first look at whether the focus is chromosomes and karyotypes, cell morphology screening, tissue sectioning and immunohistochemistry, routine clinical testing, or molecular and cellular research, and whether the role carries result interpretation, report sign-off or diagnostic support responsibility.

What kind of person is more likely suited to cytogenetic technologists?

Worth trying first: willing to do fine observation and recording for long periods at a microscope, able to carry out aseptic culture and slide preparation according to procedure, able to get every step of specimen processing, culture harvest and banding preparation right patiently, willing to verify specimen identity, batch numbers and results repeatedly, and to report non-conforming specimens and anomalies truthfully, and preferring to stop and re-verify rather than reach a conclusion from impression when the result may affect a diagnosis.Specimen information, requested tests, culture and harvest conditions, banding methods and interpretation standards may be treated as inputs that must be verified, but you must not skip specimen suitability assessment and quality control out of habit, nor continue on the basis of "issue the report first" when results conflict with quality control.

In what situations should you think carefully before choosing cytogenetic technologists?

Consider carefully: if you find it hard to stay focused on repeated microscopic observation and interpretation for long periods, have reservations about handling biological specimens and chemical reagents, are unwilling to follow standard nomenclature and documentation, or find it hard to bear the responsibility pressure of "results used for diagnosis", the actual work will differ from your expectations.A fit assessment should be checked against real work observation, mentoring feedback and your own condition; it cannot be replaced by an interest type or a single test.

How can one small experiment help you judge whether you are suited to cytogenetic technologists?

Low-risk validation: using public or fictional materials, complete one exercise — "write a specimen receipt and suitability assessment checklist — draw up a culture and harvest condition record table — count chromosomes from a fictional karyogram and write out the interpretation and the points that need escalation" — this only assesses work preferences; the exercise does not involve real patient specimens or real test procedures, and is not equivalent to training completion, practice qualification or hiring authorization.All paper exercises on this page use fictional materials; in real work, specimen handling, cell culture, reagent use, microbiological and chemical exposure protection, result interpretation and report sign-off must follow laboratory biosafety standards, quality management systems and institutional procedures, and any practice activity must also meet local qualification requirements.

Career profile

Cytogenetic technologists in the United States correspond to O*NET-SOC 29-2011.01 (Cytogenetic Technologists). The official scope is: analysing chromosomes or chromosome segments in biological specimens (such as amniotic fluid, bone marrow, solid tumours and blood) to assist in the study, diagnosis, classification or treatment of inherited or acquired genetic disease; and carrying out the analysis through classical cytogenetics, fluorescence in situ hybridisation (FISH) or microarray comparative genomic hybridisation (aCGH) techniques. Duties include receiving and assessing whether a specimen is suitable for the requested test; preparing specimens and culture media using aseptic technique, culturing cells and harvesting them in the optimal time sequence and manner; preparing cell culture slides, selecting a banding method and staining so that chromosomes are visible; counting chromosomes and identifying structural abnormalities with a microscope, light microscope or photomicrography system and arranging chromosomes in pairs on a karyogram; extracting, measuring and diluting deoxyribonucleic acid (DNA) for microarray analysis; describing chromosome, FISH and aCGH analysis results according to the International System for Human Cytogenomic Nomenclature (ISCN) and summarising and reporting them; recording specimen handling, analysis and technical problems in logs or the laboratory information system; maintaining microscopic and imaging equipment; implementing quality control and quality assurance programmes; archiving case materials according to regulations and policy; and guiding junior staff and delivering training for interns, medical students and researchers. The preparation level for this occupation is Job Zone Four (considerable preparation needed, SVP 7.0 to below 8.0), and respondents' opinion on the education needed by new employees is 100% a bachelor's degree (not the composition of employees, a unified recruitment requirement or a statutory threshold). On O*NET, the tasks, work context and preparation level of this subcategory (29-2011.01) follow its own basis, but its wage, employment and industry data are published under the combined statistics for "Clinical Laboratory Technologists and Technicians" (29-2010), and citations must state the source period and the proxy relationship. On the Chinese side, comparable positions are cytogenetics/chromosome testing positions in medical institutions and third-party medical laboratory organisations, and the two classification systems are not one-to-one: this page does not apply U.S. preparation levels, wages or qualifications to mainland China, nor does it merge the duties of cytotechnologists, histotechnologists, histology technicians, medical and clinical laboratory technologists/technicians, molecular and cellular biologists, bioengineers and biomedical engineers, or nuclear medicine technologists into this occupation.

Structured occupational profile notes

Cytogenetic Technologists: how should this work be understood?

Cytogenetic testing work can be divided into three connected but distinct work areas. The first is specimen receipt and cell culture harvest: receiving specimens such as amniotic fluid, bone marrow, solid tumours, blood and chorionic villi, assessing whether they are suitable for the requested test, and where necessary explaining to the referring party that a specimen is non-conforming and suggesting improvements; selecting the culture system or process according to specimen type and referral reason, preparing the specimen and culture medium using aseptic technique and maintaining the medium's pH, sterility and ability to support growth; and harvesting cells in the optimal time sequence and manner (manual or automated), treating them with blocking agents, releasing agents and fixatives. The second is slide preparation, banding and microscopic observation: preparing cell culture slides according to the standard process, selecting a banding method so that chromosome pairs can be identified, and staining so that chromosomes are visible under the microscope; applying the specimen and control to suitable slide frames, running the instrument and producing analysable results; and generating chromosome images with a computer imaging system and observing the culture slides through a microscope, light microscope or photomicrography system. The third is interpretive analysis and result reporting: counting chromosome numbers, identifying structural abnormalities, and arranging chromosomes in pairs on a karyogram according to standard cytogenetic nomenclature and convention; carrying out further analysis with methods such as FISH or aCGH and expressing the results according to the International System for Human Cytogenomic Nomenclature (ISCN); summarising test results and reporting them to physicians, patients, family members or researchers; recording specimen handling, analysis and technical problems in logs or the laboratory information system; and implementing quality control and quality assurance programmes and archiving case materials. The three work areas alternate, but their basis, risk and responsibility differ; the three technical routes of classical cytogenetics, FISH and aCGH also have different interpretation methods and reporting bases. The above is an organisation of the tasks and does not mean that every technologist may explain a diagnosis to a patient or independently issue a diagnostic report; in China, the applicable clinical laboratory measures and specific conditions apply.

Specimen receipt and cell culture harvest:

Specimen assessment and processing records, culture and harvest condition records

  1. 01Verify specimen identity and the requested test
  2. 02assess suitability
  3. 03select the culture system and medium
  4. 04inoculate and culture aseptically
  5. 05harvest cells in time sequence
  6. 06fix and record conditions

Slide preparation, banding and microscopic observation:

Slide and banding quality records, analysable slides and images

  1. 01Prepare cell culture slides
  2. 02select the banding method
  3. 03stain so chromosomes are visible
  4. 04load the slide and run the instrument
  5. 05generate chromosome images
  6. 06microscopic observation and preliminary verification
Interpretive analysis and result reportingCount chromosomes and identify abnormalities → arrange pairs on a karyogram → FISH or aCGH analysis → express according to ISCN → summarise and report → record and archive

Where are the boundaries between cytogenetic technologists and adjacent cytotechnology, histotechnology and medical clinical testing positions?

Cytogenetic testing works with biological specimens such as amniotic fluid, bone marrow, solid tumours, blood and chorionic villi, along with cultured cells, slides, banding and staining reagents, and microscopic and imaging equipment; the outputs are test results named according to ISCN, karyograms and FISH/aCGH analysis conclusions, specimen processing and culture harvest records, slide and banding quality records, and quality control and equipment maintenance records; the basis for handling is the test request and specimen suitability determination, standard operating and quality control procedures, biosafety and chemical safety standards, and the institution's review and reporting paths — not the job title. This table compares cytogenetic technologists with the adjacent occupations of cytotechnologists, histotechnologists, medical and clinical laboratory technologists, and molecular and cellular biologists across seven items — core purpose, main objects and basis, core process, main outputs, responsible party, collaboration and supervision, and boundary of conclusions: adjacent occupations all involve laboratory specimen processing and testing or research, but the objects (chromosomes and karyotypes, exfoliative cell morphology, tissue sections and immunohistochemistry, routine clinical test items, molecular and cellular samples) and whether the role carries chromosome karyotype interpretation do not shift just because the occupations are adjacent; compare item by item against actual duties and the testing or research direction you work in.

DimensionMain directionsComparison direction
Core purposeAnalyse chromosomes or chromosome segments in biological specimens to assist in the study, diagnosis, classification or treatment of inherited or acquired genetic disease, and produce karyotype and FISH/aCGH analysis results named according to ISCN.Core purposes of adjacent occupations: cytotechnologists use morphological methods to screen exfoliative cell samples and flag abnormalities; histotechnologists prepare tissue into sections and carry out routine and special staining and immunohistochemistry; medical and clinical laboratory technologists perform routine clinical test items and report results; molecular and cellular biologists study life processes at the cellular and molecular level.
Main objects and basisSpecimens such as amniotic fluid, bone marrow, solid tumours, blood and chorionic villi, cultured cells and slides, banding and staining reagents; the basis is the test request and specimen suitability determination, standard operating and quality control procedures, biosafety and chemical safety standards, and the institution's review and reporting paths.Objects and basis of adjacent occupations: exfoliative cell samples and morphological interpretation standards (cytotechnologists), tissue blocks and sections, staining and immunohistochemistry processes (histotechnologists), routine test items such as blood and body fluids and reference intervals (medical and clinical laboratory technologists), experimental models and molecular detection methods (molecular and cellular biologists).
Core processVerify specimen and test → assess suitability → aseptic culture and harvest → slide preparation and banding → microscopic observation → karyotype interpretation and FISH/aCGH analysis → report according to ISCN and archive.Processes of adjacent occupations: prepare and stain slides, then screen them under the microscope and flag abnormalities (cytotechnologists); fix, dehydrate, embed and section tissue, then perform staining and immunohistochemistry (histotechnologists); run tests on instruments according to the requested tests, verify the results and report them (medical and clinical laboratory technologists); design and conduct experiments, analyse data and form research conclusions (molecular and cellular biologists).
Main outputsKaryotype and FISH/aCGH analysis results named according to ISCN, specimen assessment and culture harvest records, slide and banding quality records, quality control and equipment maintenance records.Outputs of adjacent occupations: cytology screening reports and abnormality flags (cytotechnologists), tissue sections and staining results usable for diagnosis (histotechnologists), routine test results and reports (medical and clinical laboratory technologists), research data and publications (molecular and cellular biologists).
Responsible partyResponsible for the specimens, culture and slide preparation and analysis records they undertake; operation and review follow the institution's division of labour, and diagnostic clinical test reports in China additionally require verification of the physician qualification under Article 19, so all technical result records cannot be lumped together with diagnostic reports, nor can everyone be assumed to hold report release authority.Responsible parties of adjacent occupations: cytotechnologists are responsible for screening results and flags; histotechnologists for section quality and staining results; medical and clinical laboratory technologists for routine test results; molecular and cellular biologists for research data and conclusions.
Collaboration and supervisionCollaborate with referring departments and physicians, laboratory colleagues, quality and equipment management staff, and superiors or mentors within the scope of authority, and report along the institution's review and reporting paths; when a specimen is non-conforming, culture fails, quality control does not match or results conflict with the clinical picture, pause high-risk actions, verify the facts, retain records and report and refer according to procedure.Collaboration of adjacent occupations: cytotechnologists collaborate with pathology and clinical departments; histotechnologists collaborate with pathologists; medical and clinical laboratory technologists collaborate with clinical departments and laboratory management; molecular and cellular biologists collaborate with research groups and research peers.
Boundary of conclusionsSimilar job titles do not mean the same duties: whether the focus is chromosomes and karyotypes, exfoliative cell morphology, tissue sections and immunohistochemistry, routine clinical testing, or molecular and cellular research — and whether the role carries result interpretation, reporting and diagnostic support responsibility — determines the scope of duties and how performance is assessed, and the roles cannot be swapped by title.The preparation levels and practice requirements of adjacent occupations do not apply to this occupation; verify them item by item against each occupation's official materials and the requirements of the position.

Core work

  1. 01

    Arrange and attach chromosomes in numbered pairs on karyotype charts, using standard genetics laboratory practices and nomenclature, to identify normal or abnormal chromosomes.

  2. 02

    Analyze chromosomes found in biological specimens to aid diagnoses and treatments for genetic diseases such as congenital disabilities, fertility problems, and hematological disorders.

  3. 03

    Prepare biological specimens such as amniotic fluids, bone marrow, tumors, chorionic villi, and blood, for chromosome examinations.

  4. 04

    Harvest cell cultures using substances such as mitotic arrestants, cell releasing agents, and cell fixatives.

Key occupational judgments

Six recurring professional judgments: whether the specimen meets the requirements of the test and the identity and batch number match; whether the culture system and medium are chosen correctly for the specimen type and referral reason and the harvest time and method are appropriate; whether the banding and slide quality reach an interpretable standard and the controls hold; whether chromosome counting and structural abnormality identification are accurate and the karyotype arrangement follows standard nomenclature; whether the FISH or aCGH interpretation cross-corroborates the karyotype result; and whether, when quality control does not match, results conflict with the clinical picture or the specimen is abnormal, the matter is reviewed, reported and the report held back according to procedure.

  1. 01

    Verify the specimen type, identity and batch number and assess whether the specimen is suitable for the requested test; when a specimen is non-conforming or does not match the request, explain this to the referring party and suggest improvements — do not simply proceed.

    Judgment one: Do the specimen and the requested test match?

  2. 02

    Select the culture system or process according to specimen type and referral reason, prepare the specimen and medium using aseptic technique and maintain their pH, sterility and ability to support growth, and harvest cells in the optimal time sequence and manner; unsuitable conditions lead to no analysable metaphases.

    Judgment two: Are the culture and harvest conditions correct?

  3. 03

    Prepare slides according to the standard process, select a suitable banding method and stain so that chromosome pairs can be identified and the image interpreted; substandard quality must be redone rather than interpreted reluctantly.

    Judgment three: Is the slide and banding quality adequate?

  4. 04

    Count chromosome numbers and identify structural abnormalities under the microscope or imaging system and arrange chromosomes in pairs on a karyogram, expressing them according to the International System for Human Cytogenomic Nomenclature (ISCN); errors in nomenclature or arrangement make the conclusion impossible for peers to review.

    Judgment four: Does the karyotype interpretation follow the standards?

  5. 05

    Carry out further analysis with methods such as FISH or aCGH and cross-corroborate the molecular result with the karyotype interpretation; when results are inconsistent, review the specimen, probes and interpretation process rather than reporting one of them.

    Judgment five: Do the results from multiple methods corroborate each other?

  6. 06

    When the specimen is abnormal, culture fails, quality control does not match or results conflict with the clinical picture, pause high-risk actions, verify the facts, retain records, and report and refer along the institution's review and reporting paths without releasing results on your own.

    Judgment six: Have anomalies and quality control been handled?

Work reality

Work context and working conditions
Direct answer |The 30 tasks in this subcategory include culture/harvest, slide preparation and banding, karyotype/FISH/aCGH analysis, LIS recording, quality control and training; core and supplementary tasks are distinguished, and guiding junior staff or communicating with patients' families is not a uniform duty for everyone. Actual clinical tasks follow qualification, method training and institutional permissions.Across institution types and specialty directions (classical cytogenetics, FISH, aCGH), the processes, interpretation methods and reporting bases differ markedly, and no blanket conclusion can be drawn from the occupation title.
Among U.S. respondents, 100% work indoors in a controlled environment every day, 80% have daily disease/infection exposure, 55% daily hazardous conditions, 35% daily contaminant exposure and 84% daily use of common protective equipment (a combined question). The frequencies are not the actual infection rate, a dose exceedance or each person's use of every item listed; no Chinese laboratory risk level is inferred.
Specimens include amniotic fluid, bone marrow, tumours, chorionic villi and blood; cultures, slides, staining and microscopic imaging and DNA microarray analysis are prepared according to the task, and operating rights cannot be acquired through a tool name. Eight items in the 2025 U.S. posting text: Office4%, Excel4%, Outlook3%, Word1%, PowerPoint1%; the shares for Illustrator, C++ and Python are not provided, and no 0 is filled in and no non-use is inferred. A posting mention is not on-site adoption, proficiency or generative AI adoption; task tools such as LIS and imaging are kept separate from the hot technology statistics.
How the tasks are organized |Advance according to test batches and culture cycles: after taking over a shift, first verify the pending specimens and requested tests, specimen identity and batch numbers, whether cultures have reached the harvest time point, whether quality control and equipment status are normal, and any analysis left unfinished by the previous shift,Then in order assess the specimen, inoculate and culture, harvest cells on time, prepare slides and band, observe under the microscope and interpret, carry out FISH or aCGH analysis and summarise and report according to standard nomenclature; before handover, organise unfinished batches and items awaiting re-verification and hand over according to procedure; when a specimen is non-conforming, culture fails, quality control does not match or results conflict with the clinical picture, review, report and hold the report back according to procedure.
Pace and intensity
The current O*NET 29-2011.01 profile (Updated2026, not a unified survey year): 65% face time pressure every day, 45% perform repetitive motions continually or almost continually, 45% use their hands to operate and perceive more than half the time, 45% sit more than half the time and 53% make decisions every day; test batch volume and culture harvest time points determine how busy the work is, and 80% report a typical 40-hour week.
Collaboration and reporting relationships |Collaboration and reporting relationships
Collaborate with referring departments and physicians, laboratory colleagues, quality and equipment management staff, and mentors or superiors within the scope of authority,Report along the institution's review and reporting paths; the current O*NET 29-2011.01 profile (Updated2026, not a unified survey year): 84% have face-to-face discussions every day, 40% have contact with others most of the time, 45% rate collaboration with a team as important, 50% have telephone conversations once or more a week and 80% rate being accurate and precise as extremely important.
Review and chain of responsibility
The current O*NET 29-2011.01 profile (Updated2026, not a unified survey year): 45% say the consequences of error are very serious, 30% say their decisions have a "very important result" impact on coworkers or institutional results, and 45% carry very high responsibility for the health and safety of other workers; specimen handling, culture harvest, slide quality and interpretation results are reviewed according to quality control procedures; result reporting and anomaly escalation follow the institution's review path and authorization with documentation, and matters beyond your authority or results conflicting with the clinical picture must be reported and archived according to procedure.
The detailed profile currently lists 21 work styles, with attention to detail 100, conscientiousness 88 and caution 83 as Impact scores, not percentages, personality hiring thresholds or only six items. O*NET80% consider accuracy extremely important; clinical quality, safety and reporting follow the applicable rules and institutional policy.

Professional basis and boundaries of use

O*NET OnLine 29-2011.01O*NET OnLine employment trends (BLS 2025—2035 projections)O*NET OnLine summary and industry distributionPublic medical, health and laboratory employment information in ChinaILO research on generative AI and jobs
O*NET OnLine 29-2011.01
Tasks, work activities and work context percentages, preparation level (Job Zone Four), interest code IRC and work styles for Cytogenetic Technologists (29-2011.01, this subcategory's own basis)
O*NET OnLine employment trends (BLS 2025—2035 projections)
Combined 29-2010 proxy: about 343000 people in 2025; BLS Table 1.2 projects about 352400 in 2035, a net increase of about 9400, or +2.7%; the 2025—2035 annual average is about 20800 openings including growth and replacement. O*NET currently shows a Average3–4% classification label, with the precise change following BLS2.7%, and the label range is not substituted for the precise value. This is not a separately listed cytogenetics subcategory demand, immediate recruitment, an individual probability of being hired or AI causation.
O*NET OnLine summary and industry distribution
The main combined 29-2010 industry for 2025 is health care and social assistance at 83%, with the remaining 17% only an editorial difference, not an official combined other category including education and research. This subcategory is JobZone4/SVP7 to below 8; O*NET respondents' opinion on the education needed by new employees is 100% bachelor's, which is not the composition of practitioners, a unified employer requirement or a statutory threshold. The typical combined 29-2010 BLS conditions are a bachelor's degree, no related experience, and on-the-job training None, which does not mean cytogenetics specialty work needs no training; actual qualifications are verified separately by jurisdiction and task.
Public medical, health and laboratory employment information in China
Article 12 of China's measures for clinical laboratories in medical institutions requires the corresponding professional education and professional technical position qualification; Article 35 requires safety education before taking up the post and annual biosafety training. Test operation, review and diagnostic reporting differ: the reporting system in Articles 16–17 lists the operator and the reviewer; under Article 19 diagnostic clinical test reports are issued by practising physicians, with an exception for practising assistant physicians in townships, ethnic townships and towns; Article 21 states that non-clinical laboratories may not issue reports to clinical services. The specific position, method and special conditions such as prenatal diagnosis must still be verified separately, and the technologist title does not confer physician diagnostic or reporting authority. Industry wages can only be matched to the industry the actual employer belongs to.
ILO research on generative AI and jobs
The ILO abstract is a broad-scope reference on task exposure; this round did not verify a matching score, adoption or net employment causation for this occupation, and it cannot be asserted on that basis that the full research has no occupation-specific data.

Career direction comparison

How does a cytogenetic technologist compare with adjacent testing and research directions?

The table below compares cytogenetic technologists with five adjacent directions across four items — occupational direction, core work and outputs, key differences, and what it suits better; occupation codes follow the O*NET-SOC convention, and sharing a medical laboratory or life science setting does not mean duties, interpretation methods or qualifications can be swapped.

Comparing occupational directions, work outputs and selection conditions
Occupational directionCore work and outputsKey differencesWhat choice it suits better
Cytotechnologists (adjacent occupation, 29-2011.02)Use morphological methods to screen exfoliative cell samples under the microscope, identify and flag abnormal cells and support pathological diagnosis.The difference is that the objects are exfoliative cell morphology and the outputs are screening reports and abnormality flags; this occupation centres on chromosome karyotypes and molecular cytogenetic analysis and must carry out chromosome counting and structural abnormality interpretation.Better suited to people who want to specialise in cell morphology screening.
Histotechnologists (adjacent occupation, 29-2011.04)Process tissue blocks into sections and complete staining and immunohistochemistry to provide readable sections for pathological diagnosis.The difference is that the objects are tissue blocks and sections and the core is fixation, dehydration, embedding and staining processes; this occupation centres on cell culture, slide preparation and banding and karyotype interpretation and does not carry out tissue section preparation.Better suited to people who want to specialise in tissue sectioning and staining.
Medical and Clinical Laboratory Technologists (adjacent occupation, 29-2011.00)Perform and review routine and specialised clinical test items, report results and assist with interpretation.The difference is that it covers many routine test items across haematology, body fluids and biochemistry and immunology; this occupation focuses on chromosome and molecular cytogenetic analysis, with different interpretation objects and methods.Better suited to people who want to work across the whole routine clinical testing workflow.
Molecular and Cellular Biologists (adjacent occupation, 19-1029.02)Study life processes at the cellular and molecular level, design and conduct experiments and form research conclusions.The difference is that it is oriented to research questions and experimental design, with research data and conclusions as outputs; this occupation is oriented to routine test results and reports and is constrained by quality control and reporting paths.Better suited to people who want to do exploratory research rather than routine testing.
Bioengineers and Biomedical Engineers (adjacent occupation, 17-2031.00)Apply engineering methods to biological and medical problems, and design and improve instruments, processes or analytical systems.The difference is that the core is designing and developing instruments, processes or analytical systems; this occupation uses existing methods and equipment to complete testing and does not carry out system design and development.Better suited to people who want to do engineering design and technical development.
Nuclear Medicine Technologists (adjacent occupation, 29-2033.00)Prepare and administer radiopharmaceuticals, operate imaging equipment and generate images for diagnosis.The difference is that the objects are radiopharmaceuticals and imaging equipment and radiation safety procedures must be followed; this occupation does not handle radiopharmaceuticals, its core being chromosome and molecular cytogenetic analysis.Better suited to people who want to carry out imaging operations under radiation protection procedures.

How to choose

Conclusion: these directions all involve fine observation and analysis in medical laboratory or life science settings, but the objects (chromosomes and karyotypes, exfoliative cell morphology, tissue sections, routine clinical test items, molecular and cellular research, instrument and process design, radiopharmaceuticals and imaging) and whether the role carries chromosome karyotype interpretation differ markedly; when choosing, go by the actual duties, methods and testing or research direction of the target position, not just the occupation title.

Next step: using the fictional exercises on this page or one laboratory shadowing session, verify whether the object of the target direction is chromosomes and karyotypes, exfoliative cell morphology, tissue sections, routine clinical test items or molecular and cellular research, and then decide on a direction.

AI's impact on the occupation

How will AI and automation affect cytogenetic technologists?

What was verified is 30 tasks, general work context and posting keywords. This round has no AI adoption rate, measured efficiency gain, displacement date or income and employment causation. Automatic scanning, image localisation and preliminary karyotype arrangement and LIS summarisation are editorial candidates awaiting verification; general instruments and information systems are not generative AI. Application requires validating method suitability, false negatives and false positives, version and human review, and tool output does not automatically acquire clinical reporting authority. AI Impact Score 25% is an editorial estimate. Model impact index for three equally weighted representative core tasks; not a measured share of working time or a job-loss probability. floor((0+0+75)/3+0.5)=25; fermatmind-ai-impact-v1; 2026-10-18.The three tasks, ratings and sources are listed in the FermatMind method source record on this page.

AI assessment method and sources

FermatMind AI Impact Score estimation method v1

FermatMind / 费马测试 · 2026-10-18

  • Model impact index for three equally weighted representative core tasks; not a measured share of working time or a job-loss probability. floor((0+0+75)/3+0.5)=25; fermatmind-ai-impact-v1; 2026-10-18.
  • Anchors: 0 negligible; 25 preparation or record assistance; 50 substantial assistance; 75 most information output can be formed by AI with review; 100 almost all of the selected task can be done by AI and independently verified.
  • Culture and harvest | Culture aseptically and harvest cells | Select the culture system or process according to specimen type and referral reason, prepare the specimen and medium using aseptic technique and maintain their pH and sterility, and harvest cells in the optimal time sequence and manner (manual or automated) using blocking agents, releasing agents and fixatives. — 0/100; weight=1/3
  • Slide preparation and banding | Prepare slides and make chromosomes visible | Prepare cell culture slides according to the standard process, select a banding method to identify chromosome pairs, stain so that chromosomes are visible under the microscope, apply the specimen and control to suitable slide frames, run the instrument and produce analysable results, and generate chromosome images with a computer imaging system. — 0/100; weight=1/3
  • Interpretation and analysis | Count chromosomes and identify abnormalities | Observe the slides under a microscope, light microscope or photomicrography system, count chromosome numbers, identify structural abnormalities and arrange chromosomes in pairs on a karyogram; the task profile also lists DNA extraction, measurement and dilution and analyses such as FISH and aCGH. The specific method is chosen according to the test request, the validated applicability of the method, institutional procedures and staff permissions; this does not mean that every case uses them in parallel or cross-validates them. — 75/100; weight=1/3

Editorial ratings use the existing occupational responsibilities and AI task analysis on this page. They are not adoption rates, measured effects, job-disappearance or personal-unemployment probabilities, or official scores from Stanford or another external institution. No measured time weights or future robot deployment are assumed.

Task exposure

Refers to the extent to which a task can be performed or assisted by existing technology; it does not indicate whether the employer adopts it, nor does it indicate changes in headcount or wages.

Organizational adoption

Tool changes are editorial candidates; this page did not verify actual employer adoption or run trials, and task possibility cannot be presented as realised efficiency gain. Clinical use requires applicable validation, training and permission review.

Job and income outcomes

Position and wage outcomes are the actual observation level; testing demand, institutional structure and tool investment are factors to be verified, and this round has no causal sample for this subcategory, so it is not asserted that they have jointly determined a specific change.

Task impact matrix

Comparison of AI impact on occupational tasks
Work directionTaskCurrent changeHuman control points
Specimen and test verificationAssess whether the specimen is suitable for the requested testEditorial candidate awaiting verification (not measured adoption or efficiency gain): systems can prompt test requirements and specimen conditions.The suitability determination and informing the referring party remain the responsibility of people.
Culture and harvestCulture and harvest cells using aseptic techniqueEditorial candidate awaiting verification (not measured adoption or efficiency gain): incubators and process recording tools can assist with condition monitoring.Choosing the culture system and judging the harvest time point remain the responsibility of people.
Slide preparation and bandingPrepare slides, band and stainEditorial candidate awaiting verification (not measured adoption or efficiency gain): automated staining and imaging are intended to assist consistency verification (effect not measured).The quality determination and the decision to redo remain the responsibility of people.
Microscopic observation and interpretationCount chromosomes and identify structural abnormalitiesEditorial candidate awaiting verification (not measured adoption or efficiency gain): automatic scanning and image analysis can assist localisation and preliminary arrangement.Confirming abnormalities and the final interpretation remain the responsibility of people.
Karyotype arrangementArrange chromosomes in pairs on a karyogramEditorial candidate awaiting verification (not measured adoption or efficiency gain): software can assist pair arrangement and layout generation.Verifying the arrangement and nomenclature remains the responsibility of people.
Molecular cytogenetic analysisCarry out further analysis with FISH or aCGHEditorial candidate awaiting verification (not measured adoption or efficiency gain): analysis software can assist signal counting and interpretation prompts.Review results under the method applicable to the test and institutional procedures; where method comparison is needed it is performed by personnel with the corresponding permissions, and karyotype cross-validation is not set as a requirement for all cases.
Result expression and reportingExpress according to ISCN and summarise and reportEditorial candidate awaiting verification (not measured adoption or efficiency gain): information systems can generate report drafts and retained records.Drafts are reviewed by those with the corresponding permissions; technical staff do not acquire review, diagnostic or sign-off qualifications merely because a tool can generate a report.

Why do employment evidence sources reach different conclusions?

Below, each source used on this page is listed one by one, along with what it actually regulates or measures and the limits on its use.

O*NET hot technology: 29-2011.01 (2025 U.S. posting text)

View source ↗
Subject of study
O*NET technology and hot technology statistics for Cytogenetic Technologists (29-2011.01)
Main conclusions
Eight items in the 2025 U.S. posting text: Office4%, Excel4%, Outlook3%, Word1%, PowerPoint1%; the shares for Illustrator, C++ and Python are not provided, and no 0 is filled in and no non-use is inferred. A posting mention is not on-site adoption, proficiency or generative AI adoption; task tools such as LIS and imaging are kept separate from the hot technology statistics.
Limits of use
Technology keywords are market signals; they do not measure usage rates, proficiency or job displacement.

ILO: Generative AI and Jobs—Refined Global Index (abstract)

View source ↗
Subject of study
ILO global measurement research on generative AI and occupational task exposure
Main conclusions
Measures, task by task, how close generative AI is to work tasks, rather than making job displacement predictions.
Limits of use
The ILO abstract read this round did not verify a matching score for 29-2011.01, and it cannot be asserted that the full research has no occupation-specific data; task exposure is not the same as organizational adoption, a displacement date, an individual probability of unemployment or net employment causation.

O*NET detailed profile: 29-2011.01 cytogenetic technologists

View source ↗
Subject of study
O*NET survey of tasks, work activities and work context for Cytogenetic Technologists (29-2011.01)
Main conclusions
Lists tasks such as specimen assessment, aseptic culture and harvest, slide preparation and banding, microscopic observation, karyotype arrangement, FISH and aCGH analysis and reporting according to ISCN, together with work context percentages (including 100% working indoors in a controlled environment every day, 80% exposed to disease or infection every day, 65% facing time pressure every day, and 45% rating the consequences of error as very serious).
Limits of use
This is a task and context profile and contains no technology adoption or job displacement data.

BLS Table 1.2: 29-2010 combined statistics for clinical laboratory technologists and technicians

View source ↗
Subject of study
BLS2025—2035 employment projections (combined 29-2010 proxy)
Main conclusions
Combined 29-2010 proxy: about 343000 people in 2025; BLS Table 1.2 projects about 352400 in 2035, a net increase of about 9400, or +2.7%; the 2025—2035 annual average is about 20800 openings including growth and replacement. O*NET currently shows a Average3–4% classification label, with the precise change following BLS2.7%, and the label range is not substituted for the precise value. This is not a separately listed cytogenetics subcategory demand, immediate recruitment, an individual probability of being hired or AI causation.
Limits of use
This is aggregate occupational statistics; it contains no causal data on tool adoption and does not predict a displacement date.

NIST AI RMF Core: GOVERN 3.2 etc.

View source ↗
Subject of study
NIST AI Risk Management Framework (AI RMF 1.0)
Main conclusions
The NIST voluntary AI risk framework provides governance recommendations on role responsibilities, records and human oversight; it is not mandatory clinical test method or safety regulation.
Limits of use
This is a governance framework; it does not prescribe test methods or biosafety requirements, nor does it measure the automation level of this occupation.

Why do different work directions face different impacts?

Tool changes are editorial candidates; this page did not verify actual employer adoption or run trials, and task possibility cannot be presented as realised efficiency gain. Clinical use requires applicable validation, training and permission review.

Microscopic observation and chromosome counting

What AI mainly changesEditorial candidate awaiting verification: automatic scanning and image analysis can assist localisation, counting and preliminary karyotype arrangement.

Still the responsibility of peopleConfirm abnormalities, review suspected results and take responsibility for the interpretation.

Slide and banding quality determination

What AI mainly changesEditorial candidate awaiting verification: imaging and quality indicators can prompt whether a slide reaches an interpretable standard.

Still the responsibility of peopleDecide whether to redo and judge whether the banding and controls hold.

Recording and result summarisation

What AI mainly changesEditorial candidate awaiting verification: laboratory information systems can aggregate data, generate report drafts and retain records.

Still the responsibility of peopleExpressing conclusions according to ISCN, review and release remain the responsibility of people.

When AI enters professional processes, the chain of responsibility must not break

When tools are introduced, responsibility does not transfer along with the system; below are the human control steps that can be carried out in this occupation.

  1. Confirm inputs and specimen identity

    Verify whether the specimen type, identity and batch number, the requested test and the number used by the tool are consistent; a specimen-input mismatch flows straight into subsequent interpretation.

  2. Retain human review points

    Retain human review for specimen suitability assessment, culture and harvest conditions, slide and banding quality determination, the final karyotype and FISH/aCGH interpretation and report release, and do not let tool output replace quality control procedures and institutional authorization.

  3. Records and documentation

    Specimen handling, culture harvest conditions, slide preparation and interpretation results, and quality control and equipment maintenance are retained according to institutional procedures and confirmed by the responsible person, with time and basis noted, traceable to the original specimen and tool version.

  4. Exception handling and escalation

    When the specimen is abnormal, culture fails, quality control does not match, results conflict with the clinical picture or tool output is questionable, pause high-risk actions, verify the facts and report and refer according to procedure.

  5. Training and authorization

    Automatic scanning, image analysis and information integration systems must be used by staff who are trained and operating within their permissions; unverified tool output must not be used in place of quality control requirements and institutional policy.

Professional risks of using AI

Over-reliance on automatic pre-screening

The karyotype arrangement and suspected abnormality prompts given by a tool may not suit the current slide quality and case type, and misuse can miss structural abnormalities or cause misinterpretation.

Controls:Treat tool output as a candidate, review the slide and controls according to quality control procedures, and have the final interpretation and release confirmed by authorized personnel with records kept.

Specimen identity or test mismatch

A mismatch between the specimen, the requested test and the batch number can cause another person's result to be treated as one's own, directly creating a risk of misdiagnosis.

Controls:Verify specimen identity, batch number and test according to institutional procedures; which nodes require two-person review is set by the specific procedure. On detecting a mismatch, pause the affected steps under the anomaly handling procedure, record and report, and let authorized personnel decide the subsequent handling.

Culture failure or uninterpretable slides

Unsuitable culture conditions, harvest time point or banding quality produce no analysable metaphases or uninterpretable slides, delaying diagnosis.

Controls:Record culture and harvest conditions according to procedure and evaluate slide quality; when quality is inadequate, identify the cause, take corrective action and retain records, and whether to re-prepare, re-run or re-collect is determined by the test procedure and authorization — conclusions lacking quality support must not be forced.

Biological and chemical exposure

Editorial risk note: specific specimens may involve infectious material and specific reagents may carry chemical hazards; the risk depends on the material, exposure route, dose and protective measures. It must be handled according to on-site assessment and the applicable system, and the occupational context percentages cannot be used to infer an individual's infection, disease or cumulative injury.

Controls:Use protective equipment and ventilation facilities according to biosafety and chemical safety standards, dispose of sharps and waste properly, and report exposure according to procedure.

Result reporting and communication omissions

Result expression that does not follow standard nomenclature, or insufficient communication with the clinical team, prevents the conclusion from being used correctly.

Controls:Express according to ISCN and retain the basis for interpretation, report and review results along institutional paths, and re-verify before communicating when a discrepancy with the clinical picture is found.

How should different groups respond?

People preparing to enter this occupation

First build the basics of specimen handling and aseptic technique, and chromosome counting and interpretation under the microscope, then learn FISH and aCGH methods, and develop an awareness of quality control and biosafety.

Serving technical staff

Treat tool output as candidates and prompts, retain independent review of slide quality, abnormality interpretation and result expression, and document truthfully.

Laboratory and quality management

Clarify tool use and human review points, quality control and equipment maintenance requirements, traceability rules for specimens and records and the anomaly reporting path, and write quality and safety into the procedures.

Training providers

In training, develop specimen and culture harvest, slide preparation and banding and interpretation and nomenclature, and the awareness of verification and responsibility under a human-machine division of labour.

Common questions about AI and career development

What tasks are in the official task profile for cytogenetic technologists?

O*NET lists for Cytogenetic Technologists (29-2011.01): receiving and assessing whether biological specimens are suitable for the requested test; preparing specimens and culture media using aseptic technique, culturing and harvesting cells; preparing cell culture slides and selecting a banding method and staining; counting chromosomes and identifying structural abnormalities with a microscope, light microscope or photomicrography system and arranging chromosomes in pairs on a karyogram; extracting, measuring and diluting deoxyribonucleic acid (DNA) for microarray analysis; describing results according to the International System for Human Cytogenomic Nomenclature (ISCN) and summarising and reporting them; recording specimen handling, analysis and technical problems in logs or the laboratory information system; maintaining microscopic and imaging equipment; implementing quality control and quality assurance programmes; and archiving case materials and guiding junior staff.

Source:O*NET detailed profile: 29-2011.01 cytogenetic technologistsOriginal material ↗

What technologies are commonly mentioned in this occupation's settings?

Eight items in the 2025 U.S. posting text: Office4%, Excel4%, Outlook3%, Word1%, PowerPoint1%; the shares for Illustrator, C++ and Python are not provided, and no 0 is filled in and no non-use is inferred. A posting mention is not on-site adoption, proficiency or generative AI adoption; task tools such as LIS and imaging are kept separate from the hot technology statistics.

Source:O*NET hot technology: 29-2011.01 (2025 U.S. posting text)Original material ↗

Do work context statistics show that AI will replace this occupation?

No. The O*NET work context percentages describe tasks and environmental conditions (such as the indoor environment, infection exposure, protective equipment, repetitive motions, time pressure and the consequences of error) and contain no data on changes in technology adoption, headcount or individual income.

Source:O*NET detailed profile: 29-2011.01 cytogenetic technologistsOriginal material ↗

Will technological change directly reduce jobs in this occupation?

There is no verifiable causal data for this occupation. Technical capability, organizational adoption and headcount are three different levels, and this page does not present any one of them as a conclusion.

Source:O*NET detailed profile: 29-2011.01 cytogenetic technologistsOriginal material ↗

How do official projections describe employment in this occupation?

Combined 29-2010 proxy: about 343000 people in 2025; BLS Table 1.2 projects about 352400 in 2035, a net increase of about 9400, or +2.7%; the 2025—2035 annual average is about 20800 openings including growth and replacement. O*NET currently shows a Average3–4% classification label, with the precise change following BLS2.7%, and the label range is not substituted for the precise value. This is not a separately listed cytogenetics subcategory demand, immediate recruitment, an individual probability of being hired or AI causation.

Source:BLS Table 1.2: 29-2010 combined statistics for clinical laboratory technologists and techniciansOriginal material ↗

Can task exposure research predict that jobs in this occupation will disappear?

The ILO abstract read this round did not verify a matching score for 29-2011.01, and it cannot be asserted that the full research has no occupation-specific data; task exposure is not the same as organizational adoption, a displacement date, an individual probability of unemployment or net employment causation.

Source:ILO: Generative AI and Jobs—Refined Global Index (abstract)Original material ↗

Which governance requirements cannot be omitted when introducing AI tools?

Clarifying purpose, roles, data and version records, human review and anomaly escalation are NIST voluntary governance recommendations; a medical institution's actual privacy, quality control and reporting obligations follow the applicable system separately. This page has not completed clinical validation or admission determination for any specific system.

Source:NIST AI RMF Core: GOVERN 3.2 etc.Original material ↗

If an evaluation is authorized, first verify the method, tool version, permitted data and reviewers, then compare missed and false detection and record completeness for comparable specimens; this page has not run tests, and real patient specimens or data must not be submitted to unauthorised tools.

Mainland China salary reference

Public basis and gaps for clinical laboratory and cytogenetic testing positions in mainland China

O*NET29-2011.01 is the U.S. occupational identity; occupation-level wages for China were not obtained, and it is not asserted that the official source has established no corresponding classification.

Official statistics, industry context and job postings

For cytogenetics-related positions in China, first verify the employer's actual clinical/research scope and professional registration; this round did not verify a one-to-one classification with O*NET or occupational wages, and a licence is not inferred from the name.

Mainland China (national occupation-level basis)

Insufficient evidence: the NBS2025 wage release read this round has only industry and similar groupings, and no Chinese occupation-level wage distribution for cytogenetic technologists was obtained; this does not mean that all official material is unpublished, and no zero is filled in.

Mainland China (industry background, not a recruitment quote)

Industry average proxy: 2025 annual average wage of 146,266 yuan for employed persons in urban non-private units in health and social work / 75,631 yuan for private units (order-of-magnitude reference only and must not be extrapolated to this occupation's wage): This round did not obtain Chinese occupation-level quoted pay or a one-to-one mapping between the two classification systems; clinical professional registration, personnel conditions and wage bases are each verified separately, and professional technical qualifications must not be uniformly described as physician practice qualifications.

Mainland China job postings

A Shanghai maternal-health center’s prenatal laboratory management post required a master’s degree or higher in laboratory science, a senior professional rank and familiarity with genetic testing. A Dalian reproductive laboratory technician post was open to 2024 graduates with a master’s degree or higher. Both are adjacent roles; neither table quoted pay.

Which testing position directions correspond to different education and training backgrounds?

This round actually read the NBS2025 urban unit wage release; no separately listed wage for this occupation or Chinese recruitment sample was obtained.

An editorial direction example, not a unified recruitment threshold or wage statistic
Preparation direction (conditions verified separately)Position directionNotes and verification suggestions
An editorial direction example; the statutory education requirement and actual recruitment conditions are verified separatelyMedical laboratory technology support positionThis subcategory is JobZone4/SVP7 to below 8; O*NET respondents' opinion on the education needed by new employees is 100% a bachelor's degree, which is not the composition of practitioners, a unified employer requirement or a statutory threshold. The typical combined 29-2010 conditions are a bachelor's degree, no related experience and on-the-job training None, which does not mean cytogenetics specialty work needs no training; actual qualifications are verified separately by jurisdiction and task. Target positions in China must not have admission inferred from the U.S. degree opinion.
An editorial direction example; the statutory education requirement and actual recruitment conditions are verified separatelyCytogenetics/chromosome testing positionArticle 12 of China's measures for clinical laboratories in medical institutions requires the corresponding professional education and professional technical position qualification; Article 35 requires safety education before taking up the post and annual biosafety training. Test operation, review and diagnostic reporting differ: the reporting system in Articles 16–17 lists the operator and the reviewer; under Article 19 diagnostic clinical test reports are issued by practising physicians, with an exception for practising assistant physicians in townships, ethnic townships and towns; Article 21 states that non-clinical laboratories may not issue reports to clinical services. The specific position, method and special conditions such as prenatal diagnosis must still be verified separately, and the technologist title does not confer physician diagnostic or reporting authority.
An editorial direction example; the statutory education requirement and actual recruitment conditions are verified separatelyMolecular cytogenetic analysis directionEditorial compilation: positions involving biological specimen handling, cell culture, reagent use, result interpretation and report sign-off are subject to laboratory biosafety standards, quality management systems, institutional procedures and practice qualification requirements, and duties and the operable scope must be verified against the specific position and current rules; this page does not constitute a safety or compliance determination.
An editorial direction example; the statutory education requirement and actual recruitment conditions are verified separatelyLaboratory technical supervisor or quality management directionLaboratory supervisors, testing staff and quality and safety officers are different roles and must be verified against jurisdictional rules and institutional appointment; research management experience does not automatically translate into clinical qualification.

Note: not obtaining an occupation-specific figure does not mean the official channel has never published one; this page only registers the actual scope and results of consultation and, where clearly labelled, presents an industry average proxy, without substituting U.S. data.

How is testing work arranged around specimen batches and culture cycles?

Laboratory medicine departments of general and specialist hospitals

Main employment settings: laboratory medicine and pathology departments in hospitals and genetics/prenatal diagnosis related departments, and cytogenetics/chromosome testing positions in third-party medical laboratory organisations and research institutions.

Third-party medical laboratory organisations

Medical clinical testing positions require verification of the actual professional registration, personnel qualifications, method training and reporting authority; the specific contract, position grade, bonus and performance structure were not verified this round, and industry averages are not used to infer individual wages.

Research and teaching institution laboratories

Editorial check suggestion: understand the position's pace from the actual culture cycle, harvest times, specimen batches and handover records, then verify the contractual shifts, bonuses and overtime. No Chinese recruitment or wage records were checked, so shift-based duty and performance pay are not generalised as industry-wide facts.

Will AI or automation affect the wages for this occupation?

Insufficient evidence: AI adoption, efficiency gains and wage causation for Chinese cytogenetics positions were not verified. Scanning, imaging and recording tools are only candidates awaiting verification; industry statistics give no occupation-level effect, and it cannot be asserted that tool change can never produce measurable data.

U.S. salary reference

How should the wages and employment of U.S. cytogenetic technologists be read?

U.S. wages, employment and industry are all the combined Clinical Laboratory Technologists and Technicians 29-2010 statistical proxy, covering technologists and technicians; they are not a separate statistic for 29-2011.00 technologists, still less this occupation's own 29-2011.01 cytogenetic technologist data. Own tasks, context and preparation material are kept separate from the combined statistics.

Wage percentiles and the annual wage basis

Wage percentiles and the annual wage basis
Wage positionWage reference (annual)Conversion boundaries for full-year incomeHow to understand this position
Lower wage position (10th percentile)38910 dollars per year; 18.71 dollars per hour (2025 combined 29-2010 10th percentile)OEWS usually forms the standard annual wage statistic on the basis of 2080 hours per year; the officially published annual and hourly wages are used here, and an individual's actual annual income is not derived from fixed hours.A percentile is not a skill or seniority level or starting pay. This round has no decomposition of the contribution of institution, area, specialty direction or reporting management duty to wage differences, so the high band cannot be said to be typically caused by these factors.
Median wage position62930 dollars per year; 30.26 dollars per hour (2025 combined 29-2010 median)Not the same as fixed monthly incomeThe median marks the midpoint of the distribution: under this basis, half of workers are below and half above that value; it is not the average starting pay and does not mean it is reached upon entry.
Higher wage position (90th percentile)100990 dollars per year; 48.55 dollars per hour (2025 combined 29-2010 90th percentile)Does not mean sustained high income all yearInsufficient evidence: this subcategory's own wages, individual starting pay or take-home income were not verified. The combined statistics publish annual and hourly wages directly, and they are not interconverted on this page; 65% facing daily deadlines cannot be used to infer overtime, shifts or sustained income.

Salary · 10th percentile (annual):38910 dollars per year; 18.71 dollars per hour (2025 combined 29-2010 10th percentile);The 10th percentile is the low-end statistical position of the annual wage distribution under this basis, not starting pay on entry, and is not converted into individual monthly income or take-home pay;O*NET national wages: 29-2011.01 (2025 wage data, combined 29-2010 statistical proxy basis)

Salary · 25th percentile (annual):47,650 dollars per year (25th percentile, 2025 wage data; hourly 22.91 dollars; combined 29-2010 statistical proxy basis);The 25th percentile means about one quarter of workers earn less than that value per year; it is a statistical position and does not indicate a skill level;O*NET national wages: 29-2011.01 (2025 wage data, combined 29-2010 statistical proxy basis)

Salary · median (annual):62930 dollars per year; 30.26 dollars per hour (2025 combined 29-2010 median);The median indicates the midpoint of the national wage distribution under this basis; it is not the average wage, an entry-level wage or an employer offer;O*NET national wages: 29-2011.01 (2025 wage data, combined 29-2010 statistical proxy basis)

Salary · 75th percentile (annual):81,450 dollars per year (75th percentile, 2025 wage data; hourly 39.16 dollars; combined 29-2010 statistical proxy basis);The 75th percentile is the position of the upper quarter of the distribution, from the same statistical period; years of experience or job grade cannot be inferred from it;O*NET national wages: 29-2011.01 (2025 wage data, combined 29-2010 statistical proxy basis)

Salary · 90th percentile (annual):100990 dollars per year; 48.55 dollars per hour (2025 combined 29-2010 90th percentile);The 90th percentile is a statistical position, and this page has no decomposition of the wage contribution of factors or experience and does not infer an individual offer

Questions to ask when reading these numbers

What are the source and period of the U.S. wage data?

Insufficient evidence: state or area wages were not consulted this round. The national 2025 wages and 2025—2035 projections on this page are both the combined 29-2010 proxy and cannot serve as an individual offer for this subcategory or as Chinese income.

Can industry distribution represent my income?

In the 2025 combined statistics the main industry lists only health care and social assistance at 83%, and the remaining 17% is an editorial difference, so the official "other including education" wording is not carried over; the employment distribution is not industry wages or this subcategory's employer distribution.

How should percentiles be understood?

A percentile only indicates the combined 29-2010 wage position, not a job grade; with no decomposition of contributing factors, the pay reason is not inferred.

Can area wage data be treated as my offer?

Combined 29-2010 proxy: about 343000 people in 2025; BLS Table 1.2 projects about 352400 in 2035, a net increase of about 9400, or +2.7%; the 2025—2035 annual average is about 20800 openings including growth and replacement. O*NET currently shows a Average3–4% classification label, with the precise change following BLS2.7%, and the label range is not substituted for the precise value. This is not a separately listed cytogenetics subcategory demand, immediate recruitment, an individual probability of being hired or AI causation.

Which industries is this occupation distributed across?

Which industries is this occupation distributed across?
IndustryIndustry employment share / statistical statusHow to understand it
Health care and social assistanceHealth care and social assistance 83% (2025 combined 29-2010 employment, not wages)In 2025 the combined 29-2010 employment in health care and social assistance is 83%, which is not separately listed for this subcategory or an industry wage.
No other industries are separately listedThe remaining 17% is only an editorial arithmetic difference, not an official other category including educationThe remaining 17% is the 100%-83% editorial difference, and the official source does not separately list a combined other category including education and research.
Industry distribution basisThe 2025 main industry lists only health care and social assistance at 83%, with no other splitThe main industry listing is only health care and social assistance at 83%, and the difference is not split into education, research or specific employers.
Industry of cytogenetic technologists (statistical classification)Main industry health care and social assistance 83%; the remainder is not separately listed (combined 29-2010 proxy)Industry employment does not represent self-employment, employer pay or a separately listed distribution for this subcategory.

What factors make income differ for similar positions?

Available paid work

Actual take-home income should be checked separately against the contract, bonuses and hours. This round has no individual records or evidence on the prevalence of shift work, and deadline pressure is not the same as overtime.

Task scope and pay basis

Duties under the same occupation title vary considerably: across institution types and specialty directions (classical cytogenetics, FISH, aCGH), the processes, interpretation methods and reporting responsibility differ, corresponding to different skills and scopes of responsibility.

Workplace and living arrangements

Area, institution and cost of living are editorial suggestions for verifying an individual offer; this page has no causal decomposition of their contribution to wage percentile differences.

How should employment projections be read?

Occupational fit guide

Do your work preferences match those of a cytogenetic technologist?

Fit is not a personality judgement; it is about matching the real demands of daily work — fine observation and interpretation at the microscope for long periods, aseptic culture and slide preparation and banding according to procedure, verifying specimen identity, culture conditions and interpretation standards item by item, retaining review and escalation when results may affect a diagnosis, and documenting according to quality control and institutional procedures —Check it item by item against what you can tolerate.

Worth exploring further: People who can coordinate hand and eye for fine observation, are willing to verify specimens and results repeatedly according to procedure, can stay cautious and curious during long interpretation sessions, and are willing to record anomalies truthfully usually adapt more easily.

Verify the real conditions first: First verify the real shape of the work: the share of long sitting and fine observation at the microscope, the biological specimen and chemical reagent exposure protection requirements, shift arrangements, and whether you accept being reviewed by quality control and superiors while bearing the responsibility pressure of results used for diagnosis.

Try a small experience first: First complete one exercise using public or fictional materials — "write a specimen receipt and suitability assessment checklist — draw up a culture and harvest condition record table — count chromosomes from a fictional karyogram and write out the interpretation and the points that need escalation" — or one laboratory shadowing session, and then judge your preference.

Do not let a single test decide your career for you

Occupational interests (RIASEC)

Official source: O*NET OnLine 29-2011.01 interest code (updated in 2026)

Are my interest types close to cytogenetic testing?

The interest code O*NET publishes for Cytogenetic Technologists (29-2011.01) is IRC: Investigative corresponds to analysing chromosomes in connection with diagnostic classification, Realistic to aseptic culture, slide preparation and microscopic work, and Conventional to naming according to the standards, quality control and recording. Treat the code as a clue to the type of activity, not as a personality label.

  • Willing to analyse and interpret chromosomes and specimens.
  • Willing to verify according to standard nomenclature and quality control procedures and record truthfully.

Do not use it this way:The interest code only describes the type of activity; it does not predict work performance and does not constitute a hiring standard.

Learn about my occupational interests

Big Five traits (OCEAN)

General-purpose tool: Big Five scales describe trait tendencies, with no official occupational matching thresholds

Do my personality traits help with cytogenetic testing?

The Big Five is for self-observation only; this round has no occupational validity, thresholds or hiring prediction; verify readiness through actual task feedback such as specimen labelling, culture records, image verification and anomaly escalation, and do not say that any trait is the most directly related.

  • Able to verify according to standards and quality control procedures and keep records reliable.
  • Able to stay focused and steady under long interpretation sessions and responsibility pressure.

Do not use it this way:Trait descriptions do not diagnose personality and do not predict whether someone can handle a specific position.

Learn about my Big Five traits

Personality preferences (MBTI-type)

General-purpose tool: a type preference description, not an occupational fit assessment

Can MBTI tell me whether I am suited to test operations or to interpretation and reporting?

MBTI-type tools describe preferences and are not occupational assignment tools; the difference between test operations and interpretation and reporting lies mainly in the form of work (doing culture and slide preparation and operating versus interpreting and naming and communicating results), not in preference type. Please check with actual experience.

  • A preference for hands-on work can prompt observation of culture and slide preparation tasks and then verification through training performance; it does not imply better suitability or hiring.
  • A preference for analysis can prompt observation of karyotype verification and recording tasks; reporting authority must be verified separately, and no type-based assignment is inferred.

Do not use it this way:Type results must not be used as a basis for hiring, assignment or promotion.

Learn about my personality preferences

Motivation clues (Enneagram-type)

General-purpose tool: a motivation description, not an occupational fit assessment

Can the Enneagram help me understand why I want to do this work?

Enneagram-type tools describe motivation clues: wanting to do medical-related analytical work, wanting stable employment, or wanting to enter the genetics and testing field to build professional experience lead to different choices. Treat it as a tool for asking questions, not as a conclusion about a position.

  • Able to articulate what you want to get out of this job.
  • Willing to test whether the motivation holds up using actual job observation and mentoring feedback.

Do not use it this way:Do not treat motivation descriptions as a career choice conclusion or a basis for employment decisions.

Learn about my motivation clues

Cognitive and operational abilities

General-purpose tool: a cognitive performance description, with no official occupational threshold

What are the cognitive and operational ability requirements of this occupation?

This subcategory is JobZone4/SVP7 to below 8; O*NET respondents' opinion on the education needed by new employees is 100% a bachelor's degree, which is not the composition of practitioners, a unified employer requirement or a statutory threshold. The typical combined 29-2010 conditions are a bachelor's degree, no related experience and on-the-job training None, which does not mean cytogenetics specialty work needs no training; actual qualifications are verified separately by jurisdiction and task. Job Zone is not an IQ level, and there is no corresponding intelligence test threshold.

  • Able to verify against standard processes and the nomenclature system and express conclusions.
  • Able to complete fine operations and recording reliably according to procedure.

Do not use it this way:Cognitive test results are not used as a hiring standard and do not replace training and professional development.

Learn about my cognitive performance

Communication and emotional management

General-purpose tool: a communication and emotion description, not a threshold for the position

Are strong communication and emotional management abilities needed?

These positions require collaboration with referring departments and physicians, laboratory colleagues and quality and equipment management staff and the reporting of results; the O*NET survey shows 84% have face-to-face discussions every day, 40% have contact with others most of the time, 45% rate collaboration with a team as important and 80% rate being accurate and precise as extremely important. Emotional-type tools only provide an angle for self-observation; they are not a threshold for the position.

  • Able to explain specimens, results and abnormal situations clearly.
  • Able to stay professional under result responsibility pressure and collaboration and hold to quality control.

Do not use it this way:Do not use communication style to judge hiring or assignment, and do not treat emotional descriptions as health conclusions.

Learn about my communication clues

Which cytogenetic technologist work direction are you more likely suited to?

Cell culture and slide preparation and banding direction

A better match:Receive and assess specimens, culture and harvest cells using aseptic technique, and select a banding method and prepare and stain slides; these are observable tasks and suitability is not predicted from willingness, and clinical operation and reporting authority are verified separately.

Note:Constrained by specimen type and culture conditions; accuracy and patience must be maintained in batch and time point management.

Karyotype interpretation and result reporting direction

A better match:Count chromosomes under the microscope and imaging system, identify abnormalities, arrange pairs on a karyogram, carry out further analysis with FISH or aCGH and express conclusions according to ISCN; these are observable tasks and suitability is not predicted from willingness, and clinical operation and reporting authority are verified separately.

Note:Constrained by standard nomenclature and quality control procedures; consistency and caution are required under interpretation responsibility pressure.

Cytotechnologists (adjacent occupation)

A better match:Use morphological methods to screen exfoliative cell samples under the microscope, identify and flag abnormal cells.

Note:Already an adjacent occupation: you would need to build exfoliative cell morphology screening and interpretation skills, and verify its qualification requirements separately.

View related occupations:Cytotechnologists

Histotechnologists (adjacent occupation)

A better match:Process tissue blocks into sections and complete staining and immunohistochemistry.

Note:The core is tissue sectioning and staining processes; moving into it requires building fixation, dehydration and embedding and immunohistochemistry skills.

View related occupations:Histotechnologists

Medical and Clinical Laboratory Technologists (adjacent occupation)

A better match:Perform and review routine and specialised clinical test items, report results and assist with interpretation.

Note:Covers many routine test items; moving into it requires building knowledge of the whole clinical testing workflow and of the items.

View related occupations:Medical and Clinical Laboratory Technologists

Molecular and Cellular Biologists (adjacent occupation)

A better match:Study life processes at the cellular and molecular level, design and conduct experiments and form research conclusions.

Note:Oriented to research questions and experimental design; moving into it requires building experimental design and research analysis skills.

View related occupations:Molecular and Cellular Biologists

Common questions about occupational fit

Will repeated slide preparation, counting and verification make you lose patience?

Editorial observation point: culture batch management, microscopic observation and result verification involve repetitive tasks; you can observe verification records, errors and fatigue and combine this with mentoring feedback to judge what training and support is needed, rather than predicting competence from an attitude toward repetition.

Can you accept quality control and mentoring pointing out problems in your interpretation or slides?

Editorial observation point: within the institution's quality control and authorized review process, record slide or interpretation problems, the correction process and review feedback; whether feedback is accepted can be used to discuss work preferences but cannot be a necessary condition for being able to improve continuously.

Will specimen volume and turnaround pressure make you skip quality control or force a conclusion?

O*NET shows that 65% face time pressure every day and 45% rate the consequences of error as very serious; following quality control procedures and explaining the situation when necessary is more sound than rushing the work and skipping verification.

Would you rather do culture and slide preparation or karyotype interpretation and reporting?

Culture and slide preparation places more weight on aseptic technique and process quality, while interpretation and reporting places more weight on standard nomenclature and result expression: be clear about the target direction before deciding.

Are you willing to spend long periods at the microscope and communicate frequently with colleagues and physicians?

According to the O*NET survey, 100% work indoors in a controlled environment every day, 45% sit more than half the time, 84% have face-to-face discussions every day and 40% have contact with others most of the time; the work requires both fine observation and liaison with referring departments and colleagues.

Can you adapt to a working environment with biological specimens and chemical reagents?

80% daily disease/infection exposure, 55% hazardous conditions, 35% contaminants and 84% common protective equipment are U.S. respondent context. They are not disease rates, doses or each person's use of each item; clinical risk levels and specific protection require on-site assessment.

Can you adapt to the pace created by shifts and culture cycles?

65% of U.S. respondents face strict deadlines every day; a typical week is 40 hours for 80%, and this cannot be used to infer that China generally works shifts or has widespread overtime or night work. Culture harvest times are in the task profile, and the target employer's rosters, handover and breaks are verified separately.

Are you willing to keep practising slide preparation, interpretation and quality control?

Editorial observation point: record how specific tasks were completed, errors and mentoring feedback in slide preparation, interpretation and quality control training, and keep checking training needs; these records differ from the information described by tests and are not used to reach a personal fit conclusion or to compare predictive ability.

Can an interest or personality test decide whether I am suited to cytogenetic testing?

No. Tests describe preference clues; they do not predict work performance and do not constitute a hiring, qualification or suitability judgement; the real judgement comes from actual job observation, mentoring feedback and your own condition.

What should the next step be?

First verify fictional record exercises, then observe a real laboratory within the permitted, privacy and safety rules; practice or shadowing alone must not be used to start handling patient specimens, explaining diagnoses or signing off reports.

Work pressure, risks and occupational boundaries

What are the actual job risks for cytogenetic technologists?

The risks cluster into three categories: testing quality risks from specimen mismatch, culture failure and uninterpretable slides; health risks from biological specimen and chemical reagent exposure; and diagnostic support risks from interpretation and nomenclature errors and result reporting and communication omissions; specimen batch volume and interpretation responsibility pressure also accumulate.

Tasks and context come from this subcategory's O*NET; clinical specimens/reports and safety follow China's clinical laboratory measures, and U.S. actual bloodborne exposure and applicable laboratory chemical standards are listed separately. The risk consequences are editorial projections, not accident or disease rates; this round has no workstation testing, actual employer procedures or AI clinical validation.

01

Specimen mismatch or a broken identity chain

Typical scenarios:If identity, batch number or test is mismatched during receipt, aliquoting, culture or instrument loading, another person's result may be treated as one's own, leading to incorrect interpretation and reporting.

Main positions:Positions at each stage of receipt, aliquoting, culture and instrument loading

Possible consequences:Editorial risk projection (not measured incidence or causation): specimen mismatch may cause misdiagnosis, repeat sampling and loss of trust.

Reducing risk:Verify identity, test and records item by item according to the institution's specimen receipt/handling procedure; the necessary review nodes are set by the actual procedure, and this page does not infer statutory two-person review for every step from general legal provisions. Suspected mismatches are paused and escalated according to procedure with traceable records kept.

Basis:O*NET detailed profile: 29-2011.01 cytogenetic technologists · Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)

02

Culture failure or uninterpretable slides

Typical scenarios:Editorial risk projection (not measured incidence or causation): an unsuitable choice of culture system, an inappropriate medium state, a poor harvest time point or poor banding quality may produce no analysable metaphases or uninterpretable slides, delaying diagnosis or forcing repeat specimen collection.

Main positions:Positions responsible for cell culture, harvest and slide preparation and banding

Possible consequences:Editorial risk projection (not measured incidence or causation): culture failure and poor quality slides may delay diagnosis and waste specimen and working time.

Reducing risk:Record culture and harvest conditions according to procedure and evaluate slide quality; when quality is inadequate, identify the cause, take corrective action and retain records, and whether to re-prepare, re-run or re-collect is determined by the test procedure and authorization — conclusions lacking quality support must not be forced.

Basis:O*NET detailed profile: 29-2011.01 cytogenetic technologists · Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)

03

Interpretation and nomenclature errors

Typical scenarios:Editorial risk projection (not measured incidence or causation): errors in chromosome counting, structural abnormality identification or nomenclature expression may make the conclusion impossible for peers to review, or under-report or misreport an abnormality, affecting diagnosis and subsequent management.

Main positions:Positions responsible for karyotype interpretation, FISH/aCGH analysis and result expression

Possible consequences:Editorial risk projection (not measured incidence or causation): interpretation and nomenclature errors may affect the quality of diagnostic support.

Reducing risk:Verify counts/abnormalities and quality control according to the currently applicable nomenclature and validated methods; FISH, aCGH and karyotyping are not methods that every case uniformly requires together, and doubtful points are reviewed along the approved path rather than replaced by a tool draft instead of an authorized person's judgement.

Basis:O*NET detailed profile: 29-2011.01 cytogenetic technologists · Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)

04

Biological specimen and chemical reagent exposure

Typical scenarios:In the United States, 80% daily disease/infection exposure, 55% hazardous conditions, 35% contaminants and 84% common protective equipment are context frequencies; they are not the actual infection or injury proportion. The risk of specific specimens and reagents follows on-site assessment, and long-term exposure cannot be taken to necessarily accumulate injury or to be uniformly at a fixed level.

Main positions:Positions handling specimens and cultured cells and using reagents

Possible consequences:Editorial risk projection: actual uncontrolled biological or chemical exposure may cause health harm; this round has no dose, infection rate, disease rate or local incident sample.

Reducing risk:Clinical laboratories in China provide protection and training according to the actual biological hazard level and implement emergency plans; in the United States, where there is occupational exposure to blood or potentially infectious material, verify the 1910.1030 control plan, and where laboratory hazardous chemicals fall within scope verify the 1910.1450 chemical hygiene plan. Exposure is reported according to procedure and receives an appropriate assessment, and no safety level is determined from this page.

Basis:O*NET detailed profile: 29-2011.01 cytogenetic technologists · Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission) · OSHA1910.1030: occupational bloodborne pathogen exposure · OSHA1910.1450: laboratory hazardous chemical exposure

05

Result reporting and communication omissions

Typical scenarios:Editorial risk projection (not measured incidence or causation): result expression that does not follow standard nomenclature, incomplete records or insufficient clinical communication may prevent the conclusion from being used correctly; failing to re-verify promptly when results conflict with the clinical picture also amplifies the impact.

Main positions:Positions responsible for summarising results, reporting and external communication

Possible consequences:Editorial risk projection (not measured incidence or causation): reporting and communication omissions may prevent a usable conclusion from being correctly applied to diagnosis.

Reducing risk:Verify the technical record, review and report release duties; diagnostic clinical test reports in China follow the physician qualification under Article 19, and research laboratories may not issue reports to clinical services. Anomalies are escalated according to procedure and private material protected according to policy, and general "result summarisation" must not be treated as diagnostic authorization.

Basis:O*NET detailed profile: 29-2011.01 cytogenetic technologists · Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)

06

Testing volume pressure and interpretation errors

Typical scenarios:65% daily deadline pressure, 45% continual repetitive motions and 45% rating the consequences of error as Very serious (a further 25% Extremely serious) are U.S. respondent context. Skipping verification when rushing or tired is an editorial risk projection with no causal or frequency data verified.

Main positions:Positions working under specimen batch volume and deadline pressure

Possible consequences:Editorial risk projection (not measured incidence or causation): testing volume pressure may affect interpretation quality and work standards.

Reducing risk:Follow quality control procedures and review paths and secure quality and traceability before speed; when necessary, explain the situation and apply for an adjustment or report upward according to procedure.

Basis:O*NET detailed profile: 29-2011.01 cytogenetic technologists · Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)

Entering the field, certificates and career development

How do cytogenetic technologists enter the field and advance?

First separate clinical from research and test operation from physician diagnostic reporting, then verify education, professional qualification, method training and permissions. This subcategory is JobZone4/SVP7 to below 8; O*NET respondents' opinion on the education needed by new employees is 100% a bachelor's degree, which is not the composition of practitioners, a unified employer requirement or a statutory threshold. The typical combined 29-2010 conditions are a bachelor's degree, no related experience and on-the-job training None, which does not mean cytogenetics specialty work needs no training; actual qualifications are verified separately by jurisdiction and task.

Preparation and verification when entering the field

Recruitment sample and limits

Common entry-level positions and work directions

Entry-level positionWhat you mainly do at the startEditorial verification points (not an employer sample)How to demonstrate it without experienceDifference from other directions
Testing support positionUnder the guidance of a mentor, receive and register specimens, aliquot and label them, and prepare reagents and consumables and record according to procedure.Biosafety and operating standard compliance, attention to detail and record reliability.A fictional specimen receipt registration and anomaly reporting record sample.Supervised support and recording, without independent responsibility for interpretation and reporting.
Culture and slide preparation positionWithin verified qualifications, training and method permissions, assess specimens, culture and harvest and prepare and band slidesAseptic technique, culture condition control, slide quality and completeness of records.A fictional culture and harvest condition record and slide quality determination sample.Responsible for culture and slide quality, with execution according to the standards and records kept.
Karyotype interpretation positionCount chromosomes, identify structural abnormalities and arrange pairs on a karyogram, expressing conclusions according to ISCN.Interpretation accuracy, nomenclature compliance and abnormality identification ability.A fictional karyotype interpretation and nomenclature expression sample.Focused on interpretation and nomenclature, constrained by standard nomenclature and quality control procedures.
Molecular cytogenetic analysis positionWithin institutional authorization and validated methods, carry out analyses such as FISH or aCGH according to the requested test and procedure and record quality and results; whether to compare with the karyotype result depends on the test and the applicable procedure.Understanding of method suitability, quality control and result recording.A fictional FISH or aCGH result and karyotype cross-validation sample.Focused on the analysis and recording of authorized molecular cytogenetic methods and interfaces with the interpretation and reporting positions according to process.
Cytotechnologists (adjacent direction)Use morphological methods to screen exfoliative cell samples under the microscope, identify and flag abnormal cells.Morphological interpretation basics, screening standards and accuracy of flags.A fictional cytology screening record sample.The adjacent 29-2011.02 is mainly cell morphology and similar testing, while this occupation is mainly chromosomes/karyotypes; the actual tasks overlap, and the adjacent definition cannot be generalised to mean that no chromosome-related technique is ever performed.

What employers usually verify

Education and training requirements

This subcategory is JobZone4/SVP7 to below 8; O*NET respondents' opinion on the education needed by new employees is 100% a bachelor's degree, which is not the composition of practitioners, a unified employer requirement or a statutory threshold. The typical combined 29-2010 conditions are a bachelor's degree, no related experience and on-the-job training None, which does not mean cytogenetics specialty work needs no training; actual qualifications are verified separately by jurisdiction and task.

Article 12 of China's measures for clinical laboratories in medical institutions requires the corresponding professional education and professional technical position qualification; Article 35 requires safety education before taking up the post and annual biosafety training. Test operation, review and diagnostic reporting differ: the reporting system in Articles 16–17 lists the operator and the reviewer; under Article 19 diagnostic clinical test reports are issued by practising physicians, with an exception for practising assistant physicians in townships, ethnic townships and towns; Article 21 states that non-clinical laboratories may not issue reports to clinical services. The specific position, method and special conditions such as prenatal diagnosis must still be verified separately, and the technologist title does not confer physician diagnostic or reporting authority. This round did not verify a real employer posting.

Physical and working environment adaptation

In the United States, 45% sit more than half the time and 65% face daily deadline pressure, which cannot be used to infer that everyone sits for long periods or works uniform shifts; actual risk and work arrangements follow workstation assessment.

This page did not obtain unified public conditions for mainland China, which must be verified against the target employer's requirements for the current year; this page does not constitute health or hiring advice.

Observable evidence of professional ability

Able to assess specimens according to the standard process, culture aseptically and harvest, prepare and band slides and judge quality, count chromosomes under the microscope and imaging system, identify abnormalities and express conclusions according to ISCN, and to pause and report when a specimen is abnormal, culture fails, quality control does not match or results conflict with the clinical picture (from O*NET task and work context data).

The above are task and context observation points, not personality labels or hiring thresholds; the work context shows 80% exposed to disease or infection every day, 55% exposed to hazardous conditions every day, 65% facing time pressure every day and 45% rating the consequences of error as very serious.

Common objects and tool scope

Specimens such as amniotic fluid, bone marrow, solid tumours, blood and chorionic villi, cultured cells and media, slides and banding and staining reagents, probes and deoxyribonucleic acid (DNA) samples, and microscopes, inverted microscopes, photomicrography and imaging systems; the O*NET technology profile lists technology keywords such as Microsoft Outlook, Adobe Illustrator, C++, Python, Microsoft Office, Microsoft PowerPoint, Microsoft Excel and Microsoft Word.

Eight items in the 2025 U.S. posting text: Office4%, Excel4%, Outlook3%, Word1%, PowerPoint1%; the shares for Illustrator, C++ and Python are not provided, and no 0 is filled in and no non-use is inferred. A posting mention is not on-site adoption, proficiency or generative AI adoption; task tools such as LIS and imaging are kept separate from the hot technology statistics.

What work samples you can prepare without relevant experience

Work sample one: a fictional specimen receipt and suitability assessment checklist

Deliverable: a fully fictional specimen receipt and suitability assessment checklist, including identity and batch number verification items, the judgement of whether the specimen type matches the requested test, and the conditions for rejection or requesting additional material.

State the basis for each judgement (the requested test, the specimen condition or standard operating requirements); the checklist must not be self-contradictory.

Work sample two: fictional culture and slide quality records

Deliverable: a fictional culture and harvest condition record, including medium state check items, the harvest time point judgement, slide and banding quality determination criteria and the rules for redoing substandard work.

Distinguish the given data from your own judgements, explain the basis, and do not use real patient specimens or test data.

Work sample three: a fictional karyotype interpretation and nomenclature note

Deliverable: a fictional karyotype interpretation note, including the chromosome counting method, the key points of structural abnormality identification and a format example for expressing results according to the standard nomenclature system (ISCN).

Work sample four: a debrief note

Deliverable: a one-page note explaining how you would handle an abnormal specimen, a substandard slide or a result that does not meet expectations, which step takes the most time, and what you will practise next; do not include real patient specimens or unredacted test data.

What interviews and trial shifts may assess

StageWhat may be assessedObservation evidenceBoundaries of use
Basic and process Q&AWhether you can clearly explain the basic requirements and basis of specimen receipt suitability assessment, biosafety and quality control.Answer records and the process of the scenario exercise.One institution's assessment method does not represent a unified process.
Operations and quality judgementWhether you can state the sequence of review, redoing and reporting when a specimen is non-conforming, culture fails, a slide is uninterpretable or quality control does not match.Answer records and the basis for judgement.The scope of assessment is set by the institution; this page makes no inference.
Interpretation and nomenclature Q&AWhether you understand the key points of chromosome counting and structural abnormality identification and the basic requirements of karyotype arrangement and standard nomenclature expression.Answer records or an on-site demonstration.Assessment standards are set by the institution; this page makes no inference.
Mentoring or trial-shift observationThe standard of specimen handling, culture and slide preparation, interpretation recording and protection performed as required by the mentor.Mentor evaluation or trial-shift records, and a process debrief.Assessment and hiring conditions are set by the institution; this page does not constitute a hiring promise or authorization.

How to choose education, qualifications and interpretation training

Qualification/preparation itemMainly suited to whomPractical role in job seekingWhether it is a universal entry thresholdRegistration/processing conditionsInvestment considerationsImportant limits
Professional educationPeople intending to enter a laboratory positionVerify the jurisdiction and the real recruitment conditionsO*NET100% is an opinion, not uniform law; Article 12 of China's clinical measuresThe corresponding professional education and the actual position conditionsInsufficient evidence: cost or cycle not verifiedA degree does not replace professional qualification or method permissions
Clinical laboratory safety education/trainingActual clinical laboratory staffVerify pre-post and annual training recordsArticle 35 of China's measures: pre-post education and annual biosafety trainingOrganized by the unit according to law, with method training verified separatelyInsufficient evidence: unified cost or duration not verifiedTraining does not replace qualification or diagnostic reporting authority
Professional qualification, state licensing and reporting conditionsClinical personnel in the corresponding jurisdictionDistinguish operation and review from diagnostic reportingArticles 12 and 19 in China; in the United States 493.1489 applies state licensing and multiple pathwaysVerified by the specific jurisdiction, specialty and task; not all staff are physicians, and the same licence is not required across all states.Insufficient evidence: specific examination, cost or cycle not verifiedA professional technical qualification does not automatically equal physician qualification or diagnostic reporting authority
CG(ASCP) certification (U.S. professional certification)Applicants meeting the corresponding pathwayEvidence of that certification requirement and passing the examinationNot proof of Chinese admission; does not replace applicable state licensingThe U.S. CG(ASCP) professional certification is now called Scientist in Cytogenetics: Route1 recognises a bachelor's degree plus completion of a NAACLS-accredited programme within the last 5 years; Route2 requires a bachelor's in biology or chemistry, or a bachelor's plus 30 semester hours or 45 quarter hours of biochemistry courses, together with 1 year of full-time qualifying clinical experience within the last 3 years; Route3 requires a master's in genetics or molecular biology plus 6 months of full-time qualifying experience within the last 3 years. Evidence must be submitted and the examination passed; the CG(ASCPi) pathway differs and cannot be mixed. Certification does not replace state licensing or a specific position's reporting authority.The experience window follows each pathway; training fees and total cost were not verifiedCG(ASCPi) has a separate pathway; it does not equal reporting authority
FISH or aCGH specialty capabilityPeople carrying out molecular cytogenetic analysisAffects readiness for specialty positionsNot an entry threshold for all positionsAccumulated through specialty methods and case practiceInsufficient evidence: unified training cost or cycle not verifiedSpecialty capability is not equivalent to being able to release results independently.
Quality management and mentoring abilityPeople preparing to take on quality management or technical supervisor dutiesAffects competitiveness and readiness for related positionsNot an entry thresholdAccumulated through testing practice and quality managementInsufficient evidence: unified training cost or cycle not verifiedManagement ability is not equivalent to final decision authority over result interpretation or sign-off.

Boundaries of education, qualifications and interpretation training

Fictional exercise material: handling specimen suitability and slide quality problems

Fictional testing scenario material (exercise input)

Fictional scenario: a cytogenetic technologist encounters four problems during a shift. First, a bone marrow specimen is submitted for chromosome karyotype analysis, but the specimen volume is rather small and clumping is obvious; second, a batch of cultures was harvested at the routine time point and slides prepared, but after banding the chromosome spread is poor and hard to interpret; third, an initial karyotype reading suggests a structural abnormality, but the signal is weak and inconsistent with the quality control; fourth, the clinical department presses for the result before the report is issued and wants an answer as soon as possible.

Materials provided: specimen suitability assessment requirements; standard culture and harvest conditions; slide quality determination criteria and karyotype nomenclature requirements; the result reporting and anomaly reporting procedures.

Materials not provided: the rules for requesting additional material or conceding when the specimen volume is insufficient, the authority to redo and delay when banding is uninterpretable, how a suspected abnormality is submitted for review, and what may be communicated to the clinical team before the report is complete. If the exercise requires these conditions, state your assumptions and the people you need to confirm with.

Task requirements

Please write a one-page handling and reporting plan covering: the judgement and communication of specimen suitability, handling of culture and slide quality, review arrangements for a suspected structural abnormality inconsistent with quality control, and how to communicate clinically before the report is complete.

The plan must state which information comes from the given materials and which is still assumption, and indicate whether the basis is standard operating requirements, quality control procedures or the result reporting and authorization process.

Reference deliverable (can be derived from the prompt)

The plan should include: specimen suitability (verify the specimen type and volume against the requested test, and when the volume is insufficient or clumping is obvious contact the referring party to explain and suggest re-collection or supplementation rather than forcing a conclusion), slide quality (when the banding spread is poor do not force an interpretation but redo according to procedure and record the reason), suspected abnormality inconsistent with quality control (pause interpretation, review the slide and control, submit for review along the institutional path, and do not use tool output instead of human confirmation), clinical communication (explain the stage of testing and the expected time, and do not give a conclusion that has not been reviewed in advance), and handover (state the status of the four items, the actions taken and the matters still to be confirmed).

The reference deliverable only lists the elements that should be included and does not require wording identical to the example; being able to explain the basis for your judgements is enough.

Boundaries and conclusions that cannot be inferred

This item only tests specimen suitability judgement, slide quality awareness, anomaly review and communication boundary awareness; it does not evaluate whether the handling of any real case is compliant, and it does not constitute a diagnostic opinion, safety determination or legal advice.

Do not use real patient specimens or unredacted test data; where real specimen handling, cell culture, reagent use, result interpretation and report sign-off are involved, laboratory biosafety standards, quality management systems and institutional procedures must be followed, together with local qualification requirements.

A seven-day low-cost trial arrangement

  1. 01

    Day 1: Read a public document

    Find a public educational document on medical laboratory biosafety or cytogenetic testing, mark three key requirements and the corresponding practices, and write down the points you want to confirm.

  2. 02

    Day 2: Run one specimen suitability walkthrough

    Using fictional specimens and requested tests, write out the suitability assessment items and the rejection or supplementation conditions, and note the conditions that need confirmation.

  3. 03

    Day 3: Write a culture and slide quality checklist

    Using a fictional process, list the medium state check items, the harvest time point judgement and the slide quality determination criteria, marking the items that must be redone or reported.

  4. 04

    Day 4: Run one interpretation and nomenclature exercise

    Using a fictional karyogram, write out the counting method, the key points of structural abnormality identification and a format example of standard nomenclature expression.

  5. 05

    Day 5: Write an anomaly handling record

    Using a fictional scenario, write a record of reviewing, redoing and reporting a substandard slide or quality control mismatch, including the basis for judgement and the handover content.

  6. 06

    Day 6: Have someone review using only the materials

    Ask a peer to review your judgements using only your plan, and write down the questions they raise.

  7. 07

    Day 7: Decide whether to continue

    Return to the judgement checklist on this page and write down three reasons you are willing to continue and two conditions that call for caution.

How to decide on day seven whether to continue

  • Concrete change: whether you can write out the sequence of specimen suitability basis, culture and slide quality judgement, interpretation and nomenclature and anomaly review given the materials, rather than just writing "handled".
  • Facts and choices: whether you would rather do cell culture and slide preparation and banding, karyotype interpretation and result reporting, or laboratory quality and equipment.
  • Exercise load: long periods of fine observation at the microscope, interpretation responsibility pressure and the biological and chemical exposure environment — which step drains you most, and can you accept it recurring in the work.
  • Material boundaries: the exercise materials are all fictional or based on public information, and real patient specimens or unredacted test data must not be included.
  • Response to feedback: when quality control and mentoring point out problems in your slide quality or interpretation, are you willing to go back to the standards and complete them.
  • Interest in the process: even when slide preparation and counting are repetitive, are you willing to complete the quality control verification and review every time rather than skipping procedure based on experience.
  • Next step: if you are willing to continue through the first six steps, the next step is to complete, under compliant conditions (such as laboratory shadowing or one mentoring session), a full loop from specimen assessment and culture and slide preparation to interpretation and result expression, and ask someone experienced to review it; if some step is clearly draining, narrow the direction first and then verify.

Cell culture and slide preparation and banding direction

01

Testing support position

Typical duties:Under the guidance of a mentor, receive and register specimens, aliquot and label them, and prepare reagents and consumables and record according to procedure.

Advancement evidence:Able to complete support and recording according to procedure and report specimen anomalies promptly.

Qualification boundaries:Clinical positions require verification of the corresponding professional education, professional qualification and pre-post safety education/method training; the specific support role must be verified against the actual task system, and the label "support" alone cannot exempt statutory conditions.

Next step:Familiar with the specimen workflow, biosafety and laboratory standards.

02

Culture and slide preparation position

Typical duties:Within verified qualifications and method permissions, assess specimens, inoculate and culture, harvest cells on time and prepare and band slides and judge slide quality. No new method or diagnostic reporting authority is acquired through an exercise or the technologist title.

Advancement evidence:Culture and slide quality to standard, traceable records, and substandard work redone according to procedure.

Qualification boundaries:According to the institution's requirements; training in culture and slide preparation is the core basis.

Next step:Learn complex banding methods and quality control points.

03

Banding and imaging technology position

Typical duties:Optimise banding and staining conditions, run the imaging system and generate interpretable chromosome images.

Advancement evidence:Able to balance slide quality, image interpretability and batch efficiency.

Qualification boundaries:According to institutional policy and position requirements.

Next step:Learn method optimization and equipment maintenance.

04

Quality management direction (adjacent)

Typical duties:Responsible for quality control and quality assurance programmes, method validation and record management.

Advancement evidence:Able to balance quality, traceability and process efficiency.

Qualification boundaries:Usually requires testing practice experience and quality management ability, with the conditions set by institutional policy.

Next step:Verify the duties and qualification requirements of this direction.

Karyotype interpretation and result reporting direction

01

Interpretation support position

Typical duties:Under guidance, organise images, make a preliminary karyotype arrangement and enter it in standard nomenclature format, recording according to procedure.

Advancement evidence:Able to enter data accurately in the nomenclature format and submit suspected abnormalities for review promptly.

Qualification boundaries:Clinical positions require verification of the corresponding professional education, professional qualification and pre-post safety education/method training; the specific support role must be verified against the actual task system, and the label "support" alone cannot exempt statutory conditions.

Next step:Familiar with the nomenclature system and the interpretation process.

02

Karyotype interpretation position

Typical duties:Within verified qualifications and method permissions, count chromosomes, identify structural abnormalities and arrange pairs on a karyogram, expressing conclusions according to ISCN. No new method or diagnostic reporting authority is acquired through an exercise or the technologist title.

Advancement evidence:Accurate interpretation, compliant nomenclature and traceable records.

Qualification boundaries:According to the institution's requirements; cytogenetic interpretation training is the core basis.

Next step:Learn the interpretation of difficult cases and rare abnormalities.

03

Molecular cytogenetic analysis position

Typical duties:Within institutional authorization and validated methods, carry out analyses such as FISH or aCGH according to the requested test and procedure and record quality and results; whether to compare with the karyotype result depends on the test and the applicable procedure.

Advancement evidence:Able to balance consistency of results across methods, quality control and deadline requirements.

Qualification boundaries:According to institutional policy and position requirements.

Next step:Learn method development and result interpretation.

04

Review and reporting direction (adjacent)

Typical duties:Take on the review of difficult cases, result reporting and clinical communication.

Advancement evidence:Able to balance conclusion reliability, reporting standards and communication effectiveness.

Qualification boundaries:Diagnostic clinical test reports in China follow the physician qualification under Article 19 and institutional authorization; technical review and report issuance duties are verified separately, and physician authority cannot be granted by internal policy alone.

Next step:Verify the authorization and qualification requirements of this direction.

Laboratory quality and equipment direction

01

Quality support position

Typical duties:Assist with recording quality control data and organising equipment maintenance and consumable ledgers, using the record system according to procedure.

Advancement evidence:Able to complete recording and organisation according to procedure and report anomalies truthfully.

Qualification boundaries:Clinical positions require verification of the corresponding professional education, professional qualification and pre-post safety education/method training; the specific support role must be verified against the actual task system, and the label "support" alone cannot exempt statutory conditions.

Next step:Familiar with quality control and equipment management processes.

02

Quality control position

Typical duties:Execute and monitor quality control and quality assurance programmes and handle quality control deviations and records.

Advancement evidence:Complete quality control data, compliant deviation handling and traceable records.

Qualification boundaries:According to the institution's requirements; quality management training is the core basis.

Next step:Learn quality control scheme design and deviation analysis.

03

Equipment and biosafety position

Typical duties:Maintain microscopic and imaging equipment, manage biosafety and chemical safety affairs and organise training.

Advancement evidence:Able to balance equipment condition, safety requirements and staff standards.

Qualification boundaries:According to institutional policy and position requirements.

Next step:Learn equipment management and safety system development.

04

Laboratory management direction (adjacent)

Typical duties:Responsible for laboratory operations, personnel and quality management and external coordination.

Advancement evidence:Able to balance quality, safety, efficiency and staffing.

Qualification boundaries:According to institutional policy and rules.

Next step:Verify the relevant requirements for this management direction.

Ability ladder: what evidence counts for advancement?

  1. 01

    Supervised testing support position

    Under the guidance of a mentor, handle specimen receipt registration, aliquoting and labelling, reagent and consumable preparation and basic recording, able to use protective equipment according to procedure and record truthfully; the goal is to become familiar with the specimen workflow, biosafety and laboratory standards.

  2. 02

    Independently handle specimen processing and culture and slide preparation

    Within verified qualifications and method permissions, assess specimens, inoculate and culture, harvest cells on time and prepare and band slides according to process: able to work to the standards and judge slide quality, correctly identify non-conforming situations and redo or report. No new method or diagnostic reporting authority is acquired through an exercise or the technologist title.

  3. 03

    Responsible for karyotype interpretation and result expression

    Count chromosomes under the microscope and imaging system, identify structural abnormalities and arrange pairs on a karyogram, carry out further analysis with FISH or aCGH and express conclusions according to ISCN; able to judge whether a result is reliable and work with review and clinical communication.

  4. 04

    Laboratory technical supervisor or quality management direction

    Participate in quality control and quality assurance programmes, equipment maintenance, method validation and staff mentoring, or take on a specialty direction; this stage usually requires testing practice experience and quality management ability, with appointment conditions set by institutional policy.

Career outlook and moving to related occupations

Career outlook and adjacent directions for cytogenetic technologists

The official combined employment projection differs from this subcategory's actual recruitment; Chinese clinical programme demand, institutional investment and recruitment samples were not verified, so cytogenetics employment or AI displacement is not inferred from the combined net increase.A job posting can only indicate one employer's hiring need at one point in time. The three cannot substitute for one another.

Three types of data, three different bases

r5-bls-current

2025–2035

United States · U.S. combined 29-2010 proxy; not this subcategory's own figure

+2.7%

Overall change in employment

Combined 29-2010 proxy: about 343000 people in 2025; BLS Table 1.2 projects about 352400 in 2035, a net increase of about 9400, or +2.7%; the 2025—2035 annual average is about 20800 openings including growth and replacement. O*NET currently shows a Average3–4% classification label, with the precise change following BLS2.7%, and the label range is not substituted for the precise value. This is not a separately listed cytogenetics subcategory demand, immediate recruitment, an individual probability of being hired or AI causation.

Cannot show:The projection is a change in the total size of the occupation, not an individual probability of being hired; openings under this basis include growth and replacement and do not mean positions immediately increase or decrease.

O*NET OnLine: Cytogenetic Technologists certification and training entry point (29-2011.01)

Current page (updated in 2026)

United States · Cytogenetic Technologists (O*NET 29-2011.01 basis)

Certification and training look-up entry point

Certification and training information

The U.S. CG(ASCP) professional certification is now called Scientist in Cytogenetics: Route1 recognises a bachelor's degree plus completion of a NAACLS-accredited programme within the last 5 years; Route2 requires a bachelor's in biology or chemistry, or a bachelor's plus 30 semester hours or 45 quarter hours of biochemistry courses, together with 1 year of full-time qualifying clinical experience within the last 3 years; Route3 requires a master's in genetics or molecular biology plus 6 months of full-time qualifying experience within the last 3 years. Evidence must be submitted and the examination passed; the CG(ASCPi) pathway differs and cannot be mixed. Certification does not replace state licensing or a specific position's reporting authority. The certification entry points and courses are not evidence of position demand or hiring.

Cannot show:The certification and training entry point does not predict the number of positions or wage levels, and is not equivalent to practice qualification, reporting authorization or hiring.

r5-onet-current

Editorial check suggestion (2026-10-09)

Editorial compilation for this page · Cytogenetic Technologists

Criteria for verifying recruitment information (editorial compilation)

How to verify recruitment information

Editorial compilation of the criteria for verifying position information: a job posting can only indicate one employer's hiring need at one point in time.

Cannot show:A job posting does not represent national demand, the median wage or unified entry requirements.

Where can my current abilities transfer to?

These are ability adjacency relationships; they do not mean automatic promotion or that no further learning is needed.

Cytotechnologists (adjacent occupation)

Distance note: moving from chromosome karyotype interpretation to exfoliative cell morphology screening.

Transferable:Conditional editorial mapping: fine observation under the microscope, specimen handling and morphological interpretation basics apply only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: exfoliative cell morphology screening standards and cytopathology interpretation ability.

View occupation details

Histotechnologists (adjacent occupation)

Distance note: moving from cell culture and chromosome slide preparation to tissue sectioning and staining processes.

Transferable:Conditional editorial mapping: specimen handling, slide preparation and quality awareness apply only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: tissue fixation, dehydration and embedding, sectioning and immunohistochemistry technical ability.

View occupation details

Medical and Clinical Laboratory Technologists (adjacent occupation)

Distance note: moving from chromosome and molecular cytogenetic analysis to the whole routine clinical testing workflow.

Transferable:Conditional editorial mapping: laboratory testing processes, quality control and result reporting awareness apply only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: the principles, instrument operation and result interpretation ability for many routine clinical test items.

View occupation details

Molecular and Cellular Biologists (adjacent occupation)

Distance note: moving from routine testing and reporting to exploratory research.

Transferable:Conditional editorial mapping: cell culture, microscopic observation and data processing ability apply only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: experimental design, molecular detection methods and research conclusion analysis ability.

View occupation details

Bioengineers and Biomedical Engineers (adjacent occupation)

Distance note: moving from using existing methods and equipment to system design and development.

Transferable:Conditional editorial mapping: understanding of biomedical methods and equipment principles applies only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: engineering design and instrument or process development ability.

View occupation details

Medical and Clinical Laboratory Technicians (adjacent occupation)

Distance note: moving from specialist genetic testing to routine testing technique operation.

Transferable:Conditional editorial mapping: basic laboratory operations, specimen handling and recording standards apply only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: the operation and instrument use for routine test items, which usually carries separate education and qualification requirements.

View occupation details

Histology Technicians (adjacent occupation)

Distance note: moving from chromosome slide preparation to histological slide preparation.

Transferable:Conditional editorial mapping: slide preparation processes and quality awareness apply only where the actual training or duties provide the relevant experience. Adjacency does not prove that these are already held or that a direct transfer is possible.

Needs to be built:To build: tissue section preparation and routine staining operation ability.

View occupation details

Nuclear Medicine Technologists (adjacent occupation)

Distance note: moving from chromosome analysis to nuclear medicine imaging operation requires separate verification of its qualification and safety requirements.

Transferable:Conditional editorial mapping: specimen records and quality awareness may be partially shared; this occupation's tasks do not prove competence in nuclear medicine imaging, radiopharmaceuticals or radiation safety, and moving into it requires independent retraining and qualification verification.

Needs to be built:To build: radiopharmaceutical preparation, imaging equipment operation and radiation safety ability.

View occupation details

Common questions and sources

What does the daily work of a cytogenetic technologist involve?

Cytogenetic technologists prepare specimens, stain or hybridize slides, and examine chromosome number and structure. They document quality issues and submit findings under laboratory procedures. Result approval and clinical interpretation follow local roles and institutional rules.

How does cytogenetics differ from cytology?

Cytogenetics examines chromosome number, structure and karyotypes. Cytology focuses on individual cells and their morphology. Check whether the listing calls for karyotyping, FISH, cytology screening or a broader lab assignment.

How will AI affect or replace cytogenetic technologists?

Automatic scanning and image analysis can assist chromosome counting, karyotype arrangement and preliminary screening of suspected abnormalities, and laboratory information systems can assist recording, scheduling and result summarisation, which can reduce some microscopic observation, arrangement and recording work; but specimen suitability assessment, judging the culture and harvest process, slide and banding quality determination, the final interpretation and result expression of abnormal karyotypes and the review and escalation when results conflict with the clinical picture still depend on people and remain constrained by quality control procedures and reporting authorization boundaries. O*NET shows that 65% of this occupation face time pressure every day and 45% rate the consequences of error as very serious; technical exposure is not the same as organizational adoption or the disappearance of jobs.

Which tasks might software assist?

Imaging software can help arrange chromosomes, compare images and flag unusual results. Lab staff verify specimen identity, slide quality and exceptions under their procedures and authorization. This is not a measurement of AI adoption or job displacement.

Facing AI, which abilities should still be verified with priority for this occupation?

Specimen suitability assessment, aseptic culture and harvest, slide and banding quality determination, chromosome counting and structural abnormality interpretation, expressing conclusions according to the standard nomenclature, and the ability to review, report and hold back a report according to procedure.

What is the typical wage for this occupation, and how should it be compared?

These U.S. figures cover Clinical Laboratory Technologists and Technicians as a group, with no separate estimate for cytogenetics. The May 2025 U.S. median wage was $62,930 per year and $30.26 per hour. A Shanghai maternal-health center’s prenatal laboratory management post required a master’s degree or higher in laboratory science, a senior professional rank and familiarity with genetic testing. A Dalian reproductive laboratory technician post was open to 2024 graduates with a master’s degree or higher. Both are adjacent roles; neither table quoted pay.

What education does this occupation require, and how should training work?

The U.S. preparation level is Job Zone Four (SVP 7.0 to below 8.0), and the official education survey shows that 100% of this occupation requires a bachelor's degree; in mainland China, the relevant education plus laboratory and interpretation training is usually required, with some positions requiring a professional technical qualification or practice qualification, according to the target employer's rules.

Do you have to obtain a certificate to do this occupation?

O*NET provides a look-up entry point for certifications and training in this segment, but certification does not equal a licence, employer appointment, signing authority or local authorization; in mainland China, such positions mostly require laboratory biosafety and operation training according to institutional requirements, with some positions requiring a professional technical qualification or practice qualification under current rules; specific conditions should be verified against the target employer and current rules.

If you want to try this direction with no background, what should you do first?

First complete one exercise using public or fictional materials — "write a specimen receipt and suitability assessment checklist — draw up a culture and harvest condition record table — count chromosomes from a fictional karyogram and write out the interpretation and the points that need escalation" — or one laboratory shadowing session, and then verify the object, methods and qualification requirements of the target direction.

How should you read the U.S. employment projection?

BLS projects U.S. employment for U.S. SOC 29-2010 Clinical Laboratory Technologists and Technicians (parent group, not cytogenetics separately) to go from about 343,000 in 2025 to 352,400 in 2035 (+2.7%). It projects about 20,800 openings per year, including replacements.

Sources

FermatMind career content editorial team (source verification and exercise design)

Updated: 2026-10-09; statistical periods, retrieval dates and jurisdictions are listed separately.

This subcategory's own tasks and context, the combined 29-2010 national 2025 wages and 2025—2035 projection, the 2025 posting text, the Chinese health industry background, the clinical laboratory measures, the U.S. high-complexity personnel conditions and the ASCP CG pathways are cited separately; ILO and NIST are limited broad-scope references. Old names and URLs are retained with limits noted.

  • O*NET OnLine: Cytotechnologists (29-2011.02) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Cytotechnologists (29-2011.02) occupational profile
    • For comparison with exfoliative cell morphology screening in the cytotechnologist direction (adjacent occupation).
    • Do not merge cytology screening duties into this occupation.

    Limits of use:Only supports the exfoliative cell morphology screening tasks of cytotechnologists (adjacent occupation); this occupation centres on chromosome karyotypes and molecular cytogenetic analysis, and cytology screening duties are not merged into this occupation.

  • O*NET OnLine: Medical and Clinical Laboratory Technicians (29-2012.00) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Medical and Clinical Laboratory Technicians (29-2012.00) occupational profile
    • For comparison with routine testing technique in the medical and clinical laboratory technician direction (adjacent occupation).
    • Do not merge routine testing technique operation duties into this occupation.

    Limits of use:Only supports the routine clinical testing operation tasks of medical and clinical laboratory technicians (adjacent occupation); this occupation focuses on chromosome and molecular cytogenetic analysis, and routine testing technique operation duties are not merged into this occupation.

  • O*NET OnLine: Molecular and Cellular Biologists (19-1029.02) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Molecular and Cellular Biologists (19-1029.02) occupational profile
    • For comparison with experimental design and research in the molecular and cellular biologist direction (adjacent occupation).
    • Do not merge research duties into this occupation.

    Limits of use:Only supports the experimental design and research tasks of molecular and cellular biologists (adjacent occupation); this occupation produces routine test results and reports, and research duties are not merged into this occupation.

  • O*NET OnLine: Cytogenetic Technologists 29-2011.01 summary and employment trends (based on BLS 2024—2034 projections, parent occupation "Clinical Laboratory Technologists and Technicians" proxy basis)O*NET OnLine / U.S. Bureau of Labor Statistics|United States|2024—2034 projection period; retrieved 2026-09-19|official statistics
    View original material:O*NET OnLine: Cytogenetic Technologists 29-2011.01 summary and employment trends (based on BLS 2024—2034 projections, parent occupation "Clinical Laboratory Technologists and Technicians" proxy basis)
    • Supports the employment and projection figures for this occupation (parent-occupation proxy).
    • Does not include mainland China information and cannot replace mainland China data.
    • Checked this round: the original 2024–2034 facts are for protected legacy consumers; the authorized section uses the combined 29-2010 2025–2035 data and cannot be labelled as a separate 29-2011.00 statistic.

    Limits of use:The original 2024–2034 facts are for protected legacy consumers; the authorized section uses the combined 29-2010 2025–2035 data and cannot be labelled as a separate 29-2011.00 statistic.

  • Public medical laboratory and health employment information in mainland China (cytogenetics/chromosome testing positions)Public information from competent authorities and industry sources|Mainland China|Current rules; retrieved 2026-09-19|official guidance
    View original material:Public medical laboratory and health employment information in mainland China (cytogenetics/chromosome testing positions)
    • Supports the classification and employment context of such positions in mainland China.
    • Do not infer qualification, reporting authorization or wage figures from it.
    • Checked this round: the gov.cn homepage cannot support clinical reporting or personnel qualification provisions; this round lists the clinical laboratory measures that were read separately.

    Limits of use:The gov.cn homepage cannot support clinical reporting or personnel qualification provisions; this round lists the clinical laboratory measures that were read separately.

  • O*NET OnLine: Nuclear Medicine Technologists (29-2033.00) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Nuclear Medicine Technologists (29-2033.00) occupational profile
    • For comparison with imaging operation and radiation safety in the nuclear medicine technologist direction (adjacent occupation).
    • Do not merge nuclear medicine imaging duties into this occupation.

    Limits of use:Only supports the radiopharmaceutical preparation and imaging operation tasks of nuclear medicine technologists (adjacent occupation); this occupation does not handle radiopharmaceuticals, and nuclear medicine imaging duties are not merged into this occupation.

  • O*NET OnLine: Bioengineers and Biomedical Engineers (17-2031.00) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Bioengineers and Biomedical Engineers (17-2031.00) occupational profile
    • For comparison with engineering design and development in the bioengineer and biomedical engineer direction (adjacent occupation).
    • Do not merge engineering design and development duties into this occupation.

    Limits of use:Only supports the instrument, process or analytical system design tasks of bioengineers and biomedical engineers (adjacent occupation); this occupation uses existing methods and equipment to complete testing, and engineering design and development duties are not merged into this occupation.

  • O*NET OnLine: Histology Technicians (29-2012.01) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Histology Technicians (29-2012.01) occupational profile
    • For comparison with tissue sectioning and staining in the histology technician direction (adjacent occupation).
    • Do not merge histology sectioning duties into this occupation.

    Limits of use:Only supports the tissue section preparation and routine staining operation tasks of histology technicians (adjacent occupation); this occupation centres on cell culture and chromosome slide preparation, and histology sectioning duties are not merged into this occupation.

  • O*NET OnLine: Microbiologists (19-1022.00) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Microbiologists (19-1022.00) occupational profile
    • For comparison with microbiological testing and research in the microbiologist direction (adjacent occupation).
    • Do not merge microbiology duties into this occupation.

    Limits of use:Only supports the microbiological research and testing tasks of microbiologists (adjacent occupation); this occupation centres on chromosome and molecular cytogenetic analysis, and microbiology duties are not merged into this occupation.

  • O*NET OnLine: Cytogenetic Technologists summary (29-2011.01)O*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Cytogenetic Technologists summary (29-2011.01)
    • Supports observation points on entry preparation level, interest code and industry distribution.
    • Does not constitute any specific employer's hiring conditions or a threshold for mainland China.
    • Checked this round: the 2025 combined statistics list only health care and social assistance at 83% as the main industry; the 17% is an editorial difference, not an official combined other category including education and research; the 100% bachelor's figure is respondents' opinion on the requirement.

    Limits of use:The 2025 combined statistics list only health care and social assistance at 83% as the main industry; the 17% is an editorial difference, not an official combined other category including education and research; the 100% bachelor's figure is respondents' opinion on the requirement.

  • O*NET OnLine: Medical and Clinical Laboratory Technologists (29-2011.00) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Medical and Clinical Laboratory Technologists (29-2011.00) occupational profile
    • For comparison with routine clinical testing in the medical and clinical laboratory technologist direction (adjacent occupation).
    • Do not merge routine clinical testing duties into this occupation.

    Limits of use:Only supports the routine and specialised clinical testing tasks of medical and clinical laboratory technologists (adjacent occupation) and serves as the source of the proxy basis for this occupation's wage, employment and industry data; routine clinical testing duties are not merged into this occupation.

  • O*NET Interest Profiler (occupational interest questionnaire)O*NET OnLine|United States / general|Current tool; retrieved 2026-09-19|official tool
    View original material:O*NET Interest Profiler (occupational interest questionnaire)
    • The interest questionnaire is for self-observation only.
    • Must not be used as a basis for hiring, assignment or promotion.

    Limits of use:The interest questionnaire only describes experience preferences; it does not replace ability, qualification, training or hiring judgements and does not predict work performance.

  • National Bureau of Statistics: public statistics and wage release entry pointNational Bureau of Statistics|Mainland China|Current release; retrieved 2026-09-19|official statistics
    View original material:National Bureau of Statistics: public statistics and wage release entry point
    • Register the detailed levels of public wage statistics in mainland China and the industry average proxy.
    • Industry averages must not be written as this occupation's wages.
    • Checked this round: the homepage does not support specific industry values, so this round lists the 2025 health and social work direct release page separately.

    Limits of use:The homepage does not support specific industry values, so this round lists the 2025 health and social work direct release page separately.

  • NIST:Artificial Intelligence Risk Management Framework (AI RMF 1.0)National Institute of Standards and Technology|United States|AI RMF 1.0; retrieved 2026-09-19|institutional framework
    View original material:NIST:Artificial Intelligence Risk Management Framework (AI RMF 1.0)
    • For explaining governance, record-keeping and human oversight requirements when introducing AI systems.
    • The framework does not replace laboratory standards or the employer's division of responsibility.
    • Checked this round: a voluntary AI risk framework, not mandatory clinical testing regulation.

    Limits of use:A voluntary AI risk framework, not mandatory clinical testing regulation.

  • BLS Occupational Employment and Wage Statistics(OEWS)U.S. Bureau of Labor Statistics|United States|2025 wage data; retrieved 2026-09-19|official statistics
    View original material:BLS Occupational Employment and Wage Statistics(OEWS)
    • For explaining the coverage and conversion basis of wage statistics.
    • Does not provide individual income conclusions and cannot be used to derive an individual's take-home pay.

    Limits of use:Provides a wage statistics entry point published by occupation code and coverage notes; the percentile values on this page are published via the O*NET national wages page (29-2011.01) under the parent occupation "Clinical Laboratory Technologists and Technicians" (29-2011.00) proxy basis; industry average wages must not be treated as this occupation's wages, and percentiles must not be treated as starting pay.

  • O*NET OnLine: Cytogenetic Technologists (29-2011.01) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official occupation data
    View original material:O*NET OnLine: Cytogenetic Technologists (29-2011.01) occupational profile
    • Supports this occupation's tasks, work context and preparation level.
    • Contains no technology adoption or job displacement data.

    Limits of use:Supports this occupation's (29-2011.01) tasks, work activities, work context percentages, preparation level, interest code and work styles; it is a single-occupation basis and contains no technology adoption, job displacement or income change data.

  • O*NET OnLine: Cytogenetic Technologists hot technology (29-2011.01)O*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official occupation data
    View original material:O*NET OnLine: Cytogenetic Technologists hot technology (29-2011.01)
    • Supports the market signal explanation of employer technology keywords.
    • Keywords are not the same as adoption rates or ability requirements.
    • Checked this round: the eight 2025 posting text shares, not on-site software or generative AI adoption; three shares were not provided.

    Limits of use:The eight 2025 posting text shares, not on-site software or generative AI adoption; three shares were not provided.

  • National Bureau of Statistics: average annual wages of urban unit employees in 2025National Bureau of Statistics|Mainland China|2025 release basis; retrieved 2026-09-19|official statistics
    View original material:National Bureau of Statistics: average annual wages of urban unit employees in 2025
    • Register the detailed levels of public wage statistics in mainland China and the industry average proxy.
    • Industry averages must not be written as this occupation's wages.
    • Checked this round: the original source entry name and URL are retained; the industry wage this round cites the specific National Bureau of Statistics release page separately, which is not this occupation's wage.

    Limits of use:The original source entry name and URL are retained; the industry wage this round cites the specific National Bureau of Statistics release page separately, which is not this occupation's wage.

  • BLS Handbook of Methods: OEWS wages and conversion basisU.S. Bureau of Labor Statistics|United States|Current method statement; retrieved 2026-09-19|official methodology
    View original material:BLS Handbook of Methods: OEWS wages and conversion basis
    • Explains that hourly wages and annual income cannot be directly interchanged.
    • Does not provide individual income conclusions.

    Limits of use:Explains the OEWS covered population, wage composition and conversion assumptions; it does not provide specific figures for this occupation and is not used to convert hourly wages into individual monthly income.

  • O*NET OnLine: Cytogenetic Technologists national wages (29-2011.01)O*NET OnLine / U.S. Bureau of Labor Statistics|United States|2025 wage data; retrieved 2026-09-19|official statistics
    View original material:O*NET OnLine: Cytogenetic Technologists national wages (29-2011.01)
    • For explaining the statistical position and basis of wage percentiles.
    • OEWS usually forms the standard annual wage statistic on the basis of 2080 hours per year; that statistical convention cannot be used to derive an individual's actual hours, annual income or take-home pay.

    Limits of use:Publishes this occupation's annual wage percentiles of 38,910 / 47,650 / 62,930 / 81,450 / 100,990 dollars, and also publishes hourly wages (18.71 / 22.91 / 30.26 / 39.16 / 48.55); these values follow the combined Clinical Laboratory Technologists and Technicians 29-2010 statistical proxy basis, covering technologists and technicians, and are not a statistic for the 29-2011.01 subcategory itself; percentiles are statistical positions, not skill levels, and cannot be converted into individual monthly income or take-home pay; state- or area-level data must be looked up on that page by area and period.

  • O*NET OnLine: Cytogenetic Technologists certification and training entry point (29-2011.01)O*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official guidance
    View original material:O*NET OnLine: Cytogenetic Technologists certification and training entry point (29-2011.01)
    • Supports the verification entry point for certification and training information.
    • The entry point does not predict the number of positions or wage levels.

    Limits of use:Provides a look-up entry point for certifications and training in this segment, for verifying certificate and training information; certification does not equal a licence, employer appointment, signing authority or local authorization, and does not replace position training and professional technical qualification requirements in mainland China.

  • ILO:Generative AI and Jobs — A Refined Global Index of Occupational ExposureInternational Labour Organization|Global|Research publication date; retrieved 2026-09-19|institutional research
    View original material:ILO:Generative AI and Jobs — A Refined Global Index of Occupational Exposure
    • For explaining the method of measuring task-level exposure.
    • Task exposure is not the same as automation adoption or job displacement outcomes.
    • Checked this round: the abstract read this round did not verify a matching score for this occupation, and it cannot be asserted that the full research has no occupation-specific scores.

    Limits of use:The abstract read this round did not verify a matching score for this occupation, and it cannot be asserted that the full research has no occupation-specific scores.

  • O*NET OnLine: Cytogenetic Technologists detailed information (29-2011.01)O*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Cytogenetic Technologists detailed information (29-2011.01)
    • Supports tasks, work activities and work context percentages.
    • Contains no technology adoption, job count or income change data.

    Limits of use:Supports this occupation's (29-2011.01) tasks, work activities and work context percentages; that page is a single-occupation basis and contains no technology adoption or job displacement data.

  • O*NET OnLine: Histotechnologists (29-2011.04) occupational profileO*NET OnLine|United States|Page updated in 2026; retrieved 2026-09-19|official source
    View original material:O*NET OnLine: Histotechnologists (29-2011.04) occupational profile
    • For comparison with tissue sectioning and staining in the histotechnologist direction (adjacent occupation).
    • Do not merge tissue sectioning and staining duties into this occupation.

    Limits of use:Only supports the tissue sectioning, staining and immunohistochemistry tasks of histotechnologists (adjacent occupation); this occupation centres on cell culture and chromosome slide preparation, and tissue sectioning and staining duties are not merged into this occupation.

  • O*NET detailed profile: 29-2011.01 cytogenetic technologistsO*NET OnLine|United States|Page Updated2026; statistical periods listed separately; retrieved 2026-10-09|official occupation data
    View original material:O*NET detailed profile: 29-2011.01 cytogenetic technologists
    • The 30 tasks are divided into core and supplementary; 21 work styles, with attention to detail 100, conscientiousness 88 and caution 83 as Impact scores and not percentages; the 100% education figure is respondents' opinion on the education needed by new employees, not the composition of employees or a statutory threshold for all. Context proportions are not disease or accident rates; Updated is not a unified survey year.

    Limits of use:The 30 tasks are divided into core and supplementary; 21 work styles, with attention to detail 100, conscientiousness 88 and caution 83 as Impact scores and not percentages; the 100% education figure is respondents' opinion on the education needed by new employees, not the composition of employees or a statutory threshold for all. Context proportions are not disease or accident rates; Updated is not a unified survey year.

  • broader proxyU.S. Bureau of Labor Statistics|United States|2025 base year; 2025–2035 projection; retrieved 2026-10-09|official statistics
    View original material:broader proxy
    • 29-2010 is a combined statistic, not the single O*NET29-2011.00 technologist occupation or 29-2011.01 itself. 343.0 to 352.4 thousand, +9.4 thousand and +2.7%, with an annual average of 20.8 thousand openings; the O*NET Average3–4% label does not equal the precise value. The typical bachelor's degree, no related experience and on-the-job training None are the combined category's preparation and do not mean the specialty needs no training.

    Limits of use:29-2010 is a combined statistic, not the single O*NET29-2011.00 technologist occupation or 29-2011.01 itself. 343.0 to 352.4 thousand, +9.4 thousand and +2.7%, with an annual average of 20.8 thousand openings; the O*NET Average3–4% label does not equal the precise value. The typical bachelor's degree, no related experience and on-the-job training None are the combined category's preparation and do not mean the specialty needs no training.

  • broader proxyO*NET OnLine|United States|2025 OEWS national wages; retrieved 2026-10-09|official occupation data
    View original material:broader proxy
    • The page states Clinical Laboratory Technologists and Technicians; the combined 29-2010 proxy. Annual wage 10/25/50/75/90 percentiles 38910/47650/62930/81450/100990 dollars; hourly 18.71/22.91/30.26/39.16/48.55. Percentiles are not a job grade, starting pay or an individual offer and provide no causation for income differences.

    Limits of use:The page states Clinical Laboratory Technologists and Technicians; the combined 29-2010 proxy. Annual wage 10/25/50/75/90 percentiles 38910/47650/62930/81450/100990 dollars; hourly 18.71/22.91/30.26/39.16/48.55. Percentiles are not a job grade, starting pay or an individual offer and provide no causation for income differences.

  • O*NET hot technology: 29-2011.01 (2025 U.S. posting text)O*NET OnLine|United States|Full-year 2025 Lightcast U.S. posting text; retrieved 2026-10-09|official occupation data
    View original material:O*NET hot technology: 29-2011.01 (2025 U.S. posting text)
    • Eight items: Office4%, Excel4%, Outlook3%, Word1%, PowerPoint1%; Illustrator, C++ and Python are Not available, and 0 cannot be filled in or taken to mean non-use. A posting mention rate is not on-site adoption, proficiency or generative AI adoption.

    Limits of use:Eight items: Office4%, Excel4%, Outlook3%, Word1%, PowerPoint1%; Illustrator, C++ and Python are Not available, and 0 cannot be filled in or taken to mean non-use. A posting mention rate is not on-site adoption, proficiency or generative AI adoption.

  • industry contextNational Bureau of Statistics|Mainland China|2025 statistical period; released 2026-05-15; retrieved 2026-10-09|official statistics
    View original material:industry context
    • Non-private 146266 yuan and private 75631 yuan are the annual average pre-tax wages for the health and social work sector, not this occupation's median, starting pay or take-home income. They follow the urban legal entity basis with 5 or more employees, excluding self-employed individuals and freelancers; non-private does not mean only state-owned enterprises. Research employers must first be matched to their actual industry and cannot all be assigned to health care.

    Limits of use:Non-private 146266 yuan and private 75631 yuan are the annual average pre-tax wages for the health and social work sector, not this occupation's median, starting pay or take-home income. They follow the urban legal entity basis with 5 or more employees, excluding self-employed individuals and freelancers; non-private does not mean only state-owned enterprises. Research employers must first be matched to their actual industry and cannot all be assigned to health care.

  • Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)Wuxi Municipal Health Commission (carrying national health department documents)|Mainland China|Formulated 2006 / revised 2020; government page 2023-02-13; retrieved 2026-10-09|official regulation
    View original material:Measures for the management of clinical laboratories in medical institutions (2020 revision, publicly available text from the National Health Commission)
    • The national measures published by the Wuxi Municipal Health Commission: Article 6 registration of six professional diagnostic and treatment subjects; Article 12 professional education and the corresponding professional technical position qualification; Articles 15–17 specimen procedures, report issuance and the operator/reviewer; Article 19 diagnostic clinical test reports issued by practising physicians, with an assistant physician exception for townships and similar; Article 21 non-clinical laboratories may not issue reports to clinical services; Article 35 pre-post safety education and annual biosafety training; Articles 36 and 38 protection according to risk level. These apply to clinical testing in medical institutions and are not applied to all research positions; the two NHC links are HTTP412, and the government revised text that was read is used, without claiming that all current supporting rules have been verified.

    Limits of use:The national measures published by the Wuxi Municipal Health Commission: Article 6 registration of six professional diagnostic and treatment subjects; Article 12 professional education and the corresponding professional technical position qualification; Articles 15–17 specimen procedures, report issuance and the operator/reviewer; Article 19 diagnostic clinical test reports issued by practising physicians, with an assistant physician exception for townships and similar; Article 21 non-clinical laboratories may not issue reports to clinical services; Article 35 pre-post safety education and annual biosafety training; Articles 36 and 38 protection according to risk level. These apply to clinical testing in medical institutions and are not applied to all research positions; the two NHC links are HTTP412, and the government revised text that was read is used, without claiming that all current supporting rules have been verified.

  • 42CFR493.1489: qualifications of high-complexity testing personnelElectronic Code of Federal Regulations|United States|eCFRTitle42 as at 2026-10-06; retrieved 2026-10-09|official regulation
    View original material:42CFR493.1489: qualifications of high-complexity testing personnel
    • U.S. high-complexity testing personnel must hold a valid licence as required by the state and meet one of several statutory education/training pathways; a bachelor's degree is only one of them, with qualifying associate degrees and equivalent training among the others. It is not the case that all clinical testing uniformly requires a bachelor's or that all states issue the same licence; testing personnel conditions must not be treated as laboratory director or technical supervisor conditions.

    Limits of use:U.S. high-complexity testing personnel must hold a valid licence as required by the state and meet one of several statutory education/training pathways; a bachelor's degree is only one of them, with qualifying associate degrees and equivalent training among the others. It is not the case that all clinical testing uniformly requires a bachelor's or that all states issue the same licence; testing personnel conditions must not be treated as laboratory director or technical supervisor conditions.

  • ASCP BOC: Scientist in Cytogenetics CG(ASCP) qualification pathwaysAmerican Society for Clinical Pathology Board of Certification|United States|Current page; retrieved 2026-10-09|official credential requirements
    View original material:ASCP BOC: Scientist in Cytogenetics CG(ASCP) qualification pathways
    • The CG(ASCP) and CG(ASCPi) pathways differ. ASCPRoute1 recognises a bachelor's degree plus completion of a NAACLS-accredited programme within the last 5 years; Route2 specifies a bachelor's major/biochemistry courses plus 1 year of full-time qualifying clinical cytogenetics experience within the last 3 years; Route3 a master's in genetics or molecular biology plus 6 months of full-time experience within the last 3 years. Education and experience must be evidenced and the examination passed; professional certification does not replace state licensing, clinical subject registration or specific reporting authorization.

    Limits of use:The CG(ASCP) and CG(ASCPi) pathways differ. ASCPRoute1 recognises a bachelor's degree plus completion of a NAACLS-accredited programme within the last 5 years; Route2 specifies a bachelor's major/biochemistry courses plus 1 year of full-time qualifying clinical cytogenetics experience within the last 3 years; Route3 a master's in genetics or molecular biology plus 6 months of full-time experience within the last 3 years. Education and experience must be evidenced and the examination passed; professional certification does not replace state licensing, clinical subject registration or specific reporting authorization.

  • OSHA1910.1030: occupational bloodborne pathogen exposureOccupational Safety and Health Administration|United States|Current standard; retrieved 2026-10-09|official regulation
    View original material:OSHA1910.1030: occupational bloodborne pathogen exposure
    • The scope of U.S. occupational exposure where there is actual contact with blood or other potentially infectious material, and the employer's exposure control plan, engineering and work practice controls, suitable personal protection, training and post-exposure evaluation; the respondent exposure proportions cannot be used to infer infection rates or to guarantee that PPE carries zero risk.

    Limits of use:The scope of U.S. occupational exposure where there is actual contact with blood or other potentially infectious material, and the employer's exposure control plan, engineering and work practice controls, suitable personal protection, training and post-exposure evaluation; the respondent exposure proportions cannot be used to infer infection rates or to guarantee that PPE carries zero risk.

  • OSHA1910.1450: laboratory hazardous chemical exposureOccupational Safety and Health Administration|United States|Current standard; retrieved 2026-10-09|official regulation
    View original material:OSHA1910.1450: laboratory hazardous chemical exposure
    • U.S. workstations that meet the definition of laboratory use of hazardous chemicals, the employer's chemical hygiene plan, control facilities and information and training; there are scope exceptions, so it is not applied to all laboratories or production quantities, and no specific reagent dose, disease rate or Chinese law is inferred.

    Limits of use:U.S. workstations that meet the definition of laboratory use of hazardous chemicals, the employer's chemical hygiene plan, control facilities and information and training; there are scope exceptions, so it is not applied to all laboratories or production quantities, and no specific reagent dose, disease rate or Chinese law is inferred.

  • NIST AI RMF Core: GOVERN 3.2 etc.National Institute of Standards and Technology|United States|AI RMF 1.0 (2023); retrieved 2026-10-09|institutional framework
    View original material:NIST AI RMF Core: GOVERN 3.2 etc.
    • The voluntary risk management framework provides direction on human and machine responsibilities and oversight, risk records and assessment; it is not mandatory process regulation, an occupational AI adoption rate or a displacement projection.

    Limits of use:The voluntary risk management framework provides direction on human and machine responsibilities and oversight, risk records and assessment; it is not mandatory process regulation, an occupational AI adoption rate or a displacement projection.

  • ILO: Generative AI and Jobs—Refined Global Index (abstract)International Labour Organization|Global|Research abstract of 2025-05-20; retrieved 2026-10-09|institutional research
    View original material:ILO: Generative AI and Jobs—Refined Global Index (abstract)
    • A global generative AI task exposure reference; this round's abstract did not yield a matching score for 29-2011.01 or a Chinese cytogenetics position sample, and it is not claimed that the full research has no occupation-specific data. Exposure is not the same as measured adoption, degree of automation, net job change or a displacement date.

    Limits of use:A global generative AI task exposure reference; this round's abstract did not yield a matching score for 29-2011.01 or a Chinese cytogenetics position sample, and it is not claimed that the full research has no occupation-specific data. Exposure is not the same as measured adoption, degree of automation, net job change or a displacement date.

  • Three representative core tasks of this occupationFermatMind / 费马测试|2026-10-18|Editorial model estimation method
    View original material:Three representative core tasks of this occupation
    • Model impact index for three equally weighted representative core tasks; not a measured share of working time or a job-loss probability. floor((0+0+75)/3+0.5)=25; fermatmind-ai-impact-v1; 2026-10-18.
    • Anchors: 0 negligible; 25 preparation or record assistance; 50 substantial assistance; 75 most information output can be formed by AI with review; 100 almost all of the selected task can be done by AI and independently verified.
    • Culture and harvest | Culture aseptically and harvest cells | Select the culture system or process according to specimen type and referral reason, prepare the specimen and medium using aseptic technique and maintain their pH and sterility, and harvest cells in the optimal time sequence and manner (manual or automated) using blocking agents, releasing agents and fixatives. — 0/100; weight=1/3; actors.display.responsibilities_block.02[0]
    • Slide preparation and banding | Prepare slides and make chromosomes visible | Prepare cell culture slides according to the standard process, select a banding method to identify chromosome pairs, stain so that chromosomes are visible under the microscope, apply the specimen and control to suitable slide frames, run the instrument and produce analysable results, and generate chromosome images with a computer imaging system. — 0/100; weight=1/3; actors.display.responsibilities_block.03[0]
    • Interpretation and analysis | Count chromosomes and identify abnormalities | Observe the slides under a microscope, light microscope or photomicrography system, count chromosome numbers, identify structural abnormalities and arrange chromosomes in pairs on a karyogram; the task profile also lists DNA extraction, measurement and dilution and analyses such as FISH and aCGH. The specific method is chosen according to the test request, the validated applicability of the method, institutional procedures and staff permissions; this does not mean that every case uses them in parallel or cross-validates them. — 75/100; weight=1/3; actors.display.responsibilities_block.04[0]

    Limits of use:Editorial ratings use the existing occupational responsibilities and AI task analysis on this page. They are not adoption rates, measured effects, job-disappearance or personal-unemployment probabilities, or official scores from Stanford or another external institution. No measured time weights or future robot deployment are assumed.

  • parent_occupationU.S. Bureau of Labor Statistics|United States|2025–2035|Official statistics
    View original material:parent_occupation
    • BLS projects U.S. employment for U.S. SOC 29-2010 Clinical Laboratory Technologists and Technicians (parent group, not cytogenetics separately) to go from about 343,000 in 2025 to 352,400 in 2035 (+2.7%). It projects about 20,800 openings per year, including replacements.

    Limits of use:Annual openings include replacement; they are not net change or hiring odds.

  • Shanghai prenatal laboratory management (adjacent role)Shanghai Human Resources and Social Security Bureau|Mainland China|2026|Public job posting sample
    View original material:Shanghai prenatal laboratory management (adjacent role)
    • Master’s or higher in laboratory science, senior professional rank, laboratory credentials and genetic-testing knowledge. No pay listed.

    Limits of use:Individual posting, not national wage statistics.

  • Dalian reproductive laboratory technician (adjacent role)Shandong University careers portal (Dalian recruitment attachment)|Mainland China|2024|Public job posting sample
    View original material:Dalian reproductive laboratory technician (adjacent role)
    • Code 08, one post for 2024 graduates with a master’s degree or higher. Genetics was one listed discipline. No pay listed.

    Limits of use:Individual posting, not national wage statistics.

  • O*NET® 31.0 Core Task StatementsU.S. Department of Labor, Employment and Training Administration|United States|O*NET 31.0|Primary document
    View original material:O*NET® 31.0 Core Task Statements

    Limits of use:Verbatim Core Task Statements excerpted from the O*NET® 31.0 Database, used under CC BY 4.0. U.S. occupational scope.

  • O*NET® database license · CC BY 4.0U.S. Department of Labor, Employment and Training Administration|United States|O*NET 31.0|Primary document
    View original material:O*NET® database license · CC BY 4.0

    Limits of use:Verbatim Core Task Statements excerpted from the O*NET® 31.0 Database, used under CC BY 4.0. U.S. occupational scope.

Note: this page distinguishes official statistics, laboratory and institutional policies, and editorial compilation; source names and scopes of application are not interchangeable. U.S. wages, employment and industry are all the combined Clinical Laboratory Technologists and Technicians 29-2010 statistical proxy, covering technologists and technicians; they are not a separate statistic for 29-2011.00 technologists, still less this occupation's own 29-2011.01 cytogenetic technologist data. Own tasks, context and preparation material are kept separate from the combined statistics. 2025 wages/industry/base year and the 2025—2035 projection are listed by period; the Chinese NBS2025 pre-tax industry average does not replace occupational wages, and no specific recruitment sample was verified. Clinical and research, personnel and laboratory qualifications, operation and diagnostic reporting, and Chinese and U.S. certification and licensing are kept separate; method, privacy and safety training are not acquired through a fictional exercise.

Cytogenetic Technologists | FermatMind